TW201347687A - Polyphenol stabilizer, and composition and processed goods containing said stabilizer - Google Patents
Polyphenol stabilizer, and composition and processed goods containing said stabilizer Download PDFInfo
- Publication number
- TW201347687A TW201347687A TW102110041A TW102110041A TW201347687A TW 201347687 A TW201347687 A TW 201347687A TW 102110041 A TW102110041 A TW 102110041A TW 102110041 A TW102110041 A TW 102110041A TW 201347687 A TW201347687 A TW 201347687A
- Authority
- TW
- Taiwan
- Prior art keywords
- stabilizer
- polyphenol
- ellagic acid
- beverage
- weight
- Prior art date
Links
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 187
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 187
- 239000003381 stabilizer Substances 0.000 title claims abstract description 113
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims abstract description 107
- 229920002079 Ellagic acid Polymers 0.000 claims abstract description 107
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims abstract description 107
- 235000004132 ellagic acid Nutrition 0.000 claims abstract description 107
- 229960002852 ellagic acid Drugs 0.000 claims abstract description 107
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims abstract description 107
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims abstract description 72
- 235000005487 catechin Nutrition 0.000 claims abstract description 72
- 229940109529 pomegranate extract Drugs 0.000 claims abstract description 47
- 235000013305 food Nutrition 0.000 claims abstract description 43
- 150000001765 catechin Chemical class 0.000 claims abstract description 40
- 238000006345 epimerization reaction Methods 0.000 claims abstract description 35
- 239000000419 plant extract Substances 0.000 claims abstract description 33
- 239000003814 drug Substances 0.000 claims abstract description 26
- 230000006641 stabilisation Effects 0.000 claims abstract description 26
- 238000011105 stabilization Methods 0.000 claims abstract description 26
- 239000002537 cosmetic Substances 0.000 claims abstract description 18
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229920002414 procyanidin Polymers 0.000 claims abstract description 5
- 235000013361 beverage Nutrition 0.000 claims description 123
- 229920002770 condensed tannin Polymers 0.000 claims description 74
- 238000000034 method Methods 0.000 claims description 24
- 229930182478 glucoside Natural products 0.000 claims description 23
- 150000008131 glucosides Chemical class 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 13
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims description 9
- 239000003112 inhibitor Substances 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 6
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims description 5
- 241000508269 Psidium Species 0.000 claims description 4
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 claims 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 claims 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 claims 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 abstract description 49
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 48
- 235000012734 epicatechin Nutrition 0.000 abstract description 35
- 244000269722 Thea sinensis Species 0.000 abstract description 27
- 244000299461 Theobroma cacao Species 0.000 abstract description 25
- 238000003860 storage Methods 0.000 abstract description 20
- 229940079593 drug Drugs 0.000 abstract description 18
- 238000000605 extraction Methods 0.000 abstract description 4
- 229920000241 Punicalagin Polymers 0.000 abstract description 3
- ZJVUMAFASBFUBG-OGJBWQGYSA-N punicalagin Chemical compound C([C@H]1O[C@@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]2[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O ZJVUMAFASBFUBG-OGJBWQGYSA-N 0.000 abstract description 3
- LMIBIMUSUFYFJN-RSVYENFWSA-N punicalagin Natural products O[C@@H]1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)cc5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8c(O)c(O)c(O)cc8C(=O)O[C@H]2[C@@H]9OC(=O)c%10cc(O)c(O)c(O)c%10c%11c(O)c(O)c(O)cc%11C(=O)O[C@@H]19 LMIBIMUSUFYFJN-RSVYENFWSA-N 0.000 abstract description 3
- ZRKSVMFLACVUIU-UHFFFAOYSA-N punicalagin isomer Natural products OC1=C(O)C(=C2C3=4)OC(=O)C=4C4=C(O)C(O)=C3OC(=O)C2=C1C1=C(O)C(O)=C(O)C=C1C(=O)OC1C2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(O)OC1COC(=O)C1=CC4=C(O)C(O)=C1O ZRKSVMFLACVUIU-UHFFFAOYSA-N 0.000 abstract description 3
- 230000007935 neutral effect Effects 0.000 abstract description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 abstract 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 abstract 1
- 235000001046 cacaotero Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 description 49
- 241000219991 Lythraceae Species 0.000 description 28
- 235000014360 Punica granatum Nutrition 0.000 description 28
- 230000000694 effects Effects 0.000 description 28
- 239000000284 extract Substances 0.000 description 26
- 235000013616 tea Nutrition 0.000 description 26
- 235000009470 Theobroma cacao Nutrition 0.000 description 24
- -1 epicatechin catechins Chemical class 0.000 description 23
- 230000005764 inhibitory process Effects 0.000 description 23
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 22
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 22
- 230000002401 inhibitory effect Effects 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- 238000012360 testing method Methods 0.000 description 21
- 230000009467 reduction Effects 0.000 description 20
- 229950001002 cianidanol Drugs 0.000 description 19
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 19
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 18
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 17
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000012264 purified product Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 11
- 230000003078 antioxidant effect Effects 0.000 description 9
- 235000004515 gallic acid Nutrition 0.000 description 9
- 229940074391 gallic acid Drugs 0.000 description 9
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 9
- 239000000825 pharmaceutical preparation Substances 0.000 description 9
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 8
- 229920001991 Proanthocyanidin Polymers 0.000 description 8
- 241001083505 Punica Species 0.000 description 8
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 8
- 229940127557 pharmaceutical product Drugs 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 7
- 238000006317 isomerization reaction Methods 0.000 description 7
- 238000004445 quantitative analysis Methods 0.000 description 7
- 229920001864 tannin Polymers 0.000 description 7
- 235000018553 tannin Nutrition 0.000 description 7
- 239000001648 tannin Substances 0.000 description 7
- 235000010208 anthocyanin Nutrition 0.000 description 6
- 239000004410 anthocyanin Substances 0.000 description 6
- 229930002877 anthocyanin Natural products 0.000 description 6
- 150000004636 anthocyanins Chemical class 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- XFZJEEAOWLFHDH-NFJBMHMQSA-N procyanidin B2 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-NFJBMHMQSA-N 0.000 description 5
- 230000000087 stabilizing effect Effects 0.000 description 5
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 4
- 229920002350 Procyanidin B2 Polymers 0.000 description 4
- 229920001263 Procyanidin B5 Polymers 0.000 description 4
- 229920001554 Procyanidin C1 Polymers 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229940030275 epigallocatechin gallate Drugs 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- GMISZFQPFDAPGI-UHFFFAOYSA-N proanthocyanidin B5 Natural products OC=1C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-UHFFFAOYSA-N 0.000 description 4
- GMISZFQPFDAPGI-CVJZBMGUSA-N procyanidin B5 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=C3C[C@H]([C@H](OC3=CC=2O)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 GMISZFQPFDAPGI-CVJZBMGUSA-N 0.000 description 4
- MOJZMWJRUKIQGL-XILRTYJMSA-N procyanidin C1 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C2=C3O[C@@H]([C@H](O)[C@H](C3=C(O)C=C2O)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)C=2C=C(O)C(O)=CC=2)=CC=C(O)C(O)=C1 MOJZMWJRUKIQGL-XILRTYJMSA-N 0.000 description 4
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 3
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 230000001973 epigenetic effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229930013799 (-)-catechin Natural products 0.000 description 2
- 235000007331 (-)-catechin Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-HIFRSBDPSA-N (-)-catechin Chemical compound C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-HIFRSBDPSA-N 0.000 description 2
- 229930013783 (-)-epicatechin Natural products 0.000 description 2
- 235000007355 (-)-epicatechin Nutrition 0.000 description 2
- BHUPIKYIGMWGAD-UHFFFAOYSA-N 2-amino-9-(hydroxymethyl)-3-oxophenoxazine-1-carboxylic acid Chemical compound C1=CC=C2OC3=CC(=O)C(N)=C(C(O)=O)C3=NC2=C1CO BHUPIKYIGMWGAD-UHFFFAOYSA-N 0.000 description 2
- JSUVCAQGWVUMPD-QXUQJYLISA-N Arjuna Natural products O([C@H]([C@@H](O)C=O)[C@H]1[C@H](O)COC(=O)c2c(c(O)c(O)c(O)c2)-c2c(O)c(O)c3OC(=O)c4c(c(O)c(O)c5OC(=O)c2c3-c45)-c2c(O)c(O)c(O)cc2C(=O)O1)C(=O)c1cc(O)c(O)c(O)c1 JSUVCAQGWVUMPD-QXUQJYLISA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000014036 Castanea Nutrition 0.000 description 2
- 241001070941 Castanea Species 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 241000147041 Guaiacum officinale Species 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- CXQWRCVTCMQVQX-UHFFFAOYSA-N cis-dihydroquercetin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-UHFFFAOYSA-N 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229930003949 flavanone Natural products 0.000 description 2
- 150000002208 flavanones Chemical class 0.000 description 2
- 235000011981 flavanones Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 229940091561 guaiac Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- TZAAYUCUPIYQBR-JGRMJRGVSA-N (+)-guaiacin Chemical compound C1([C@@H]2[C@@H](C)[C@H](C)CC=3C=C(C(=CC=32)O)OC)=CC=C(O)C(OC)=C1 TZAAYUCUPIYQBR-JGRMJRGVSA-N 0.000 description 1
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 1
- 235000004911 (-)-epigallocatechin gallate Nutrition 0.000 description 1
- WMBWREPUVVBILR-NQIIRXRSSA-N (-)-gallocatechin gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-NQIIRXRSSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LEVWXDHUVBDUSV-YWEYNIOJSA-N (z)-3-(3,4-dihydroxyphenyl)-2-hydroxyprop-2-enoic acid Chemical class OC(=O)C(\O)=C\C1=CC=C(O)C(O)=C1 LEVWXDHUVBDUSV-YWEYNIOJSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- JMGCAHRKIVCLFW-UHFFFAOYSA-N 1-O-Galloylcastalagin Natural products Oc1cc(cc(O)c1O)C(=O)OC2C3OC(=O)c4c2c(O)c(O)c(O)c4c5c(O)c(O)c(O)c6c5C(=O)OC3C7OC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OCC7OC(=O)c%10cc(O)c(O)c(O)c6%10 JMGCAHRKIVCLFW-UHFFFAOYSA-N 0.000 description 1
- YEDFEBOUHSBQBT-UHFFFAOYSA-N 2,3-dihydroflavon-3-ol Chemical compound O1C2=CC=CC=C2C(=O)C(O)C1C1=CC=CC=C1 YEDFEBOUHSBQBT-UHFFFAOYSA-N 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- QFLMUASKTWGRQE-IQXCJVCKSA-N Arecatannin A2 Natural products O[C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@@H]3[C@@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2[C@H]([C@@H](O)[C@@H](c3cc(O)c(O)cc3)Oc12)c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 QFLMUASKTWGRQE-IQXCJVCKSA-N 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- TZAAYUCUPIYQBR-UHFFFAOYSA-N Guaiacin Natural products C1=2C=C(O)C(OC)=CC=2CC(C)C(C)C1C1=CC=C(O)C(OC)=C1 TZAAYUCUPIYQBR-UHFFFAOYSA-N 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 229920001301 Hexahydroxydiphenic acid Polymers 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000819847 Pomella Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- KZTASAUPEDXWMQ-UHFFFAOYSA-N azane;iron(3+) Chemical compound N.[Fe+3] KZTASAUPEDXWMQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- QFLMUASKTWGRQE-JNIIMKSASA-N cinnamtannin A2 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C2=C3O[C@@H]([C@H](O)[C@H](C3=C(O)C=C2O)C2=C(O)C=C(O)C3=C2O[C@@H]([C@H](O)[C@H]3C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)C=2C=C(O)C(O)=CC=2)C=2C=C(O)C(O)=CC=2)=CC=C(O)C(O)=C1 QFLMUASKTWGRQE-JNIIMKSASA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- 235000020237 cranberry extract Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- ZEPCRIPMALGRJR-UHFFFAOYSA-N ellagic acid, dihydrate Chemical compound O.O.OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 ZEPCRIPMALGRJR-UHFFFAOYSA-N 0.000 description 1
- 229920001968 ellagitannin Polymers 0.000 description 1
- JMGCAHRKIVCLFW-CNWXVVPTSA-N ellagitannin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2C3=C4C(=O)O[C@@H]2[C@@H]2[C@@H]5OC(=O)C6=CC(O)=C(O)C(O)=C6C6=C(O)C(O)=C(O)C=C6C(=O)OC[C@H]5OC(=O)C5=CC(O)=C(O)C(O)=C5C=5C(O)=C(O)C(O)=C(C=5C(=O)O2)C4=C(O)C(O)=C3O)=C1 JMGCAHRKIVCLFW-CNWXVVPTSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- VFSWRBJYBQXUTE-UHFFFAOYSA-N epi-Gallocatechin 3-O-gallate Natural products Oc1ccc2C(=O)C(OC(=O)c3cc(O)c(O)c(O)c3)C(Oc2c1)c4cc(O)c(O)c(O)c4 VFSWRBJYBQXUTE-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003939 flavanonol Natural products 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical group [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000010204 pine bark Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000012748 slip agent Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical class C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明係關於多酚之安定化劑及含有該安定化劑之多酚組成物。且,本發明係關於使用上述多酚組成物而製造之飲食品、醫藥品或化妝品之含有多酚之加工製品。更詳言之,本發明係關於表(epi)體兒茶素類之差向異構化(epimerization)抑制劑及/或原花青素類之減低抑制劑、含有該等抑制劑之多酚組成物及含有多酚之加工製品。 The present invention relates to a stabilizer for a polyphenol and a polyphenol composition containing the stabilizer. Further, the present invention relates to a processed product containing polyphenols for foods and drinks, pharmaceuticals or cosmetics produced by using the above polyphenol composition. More specifically, the present invention relates to an epimerization inhibitor and/or a proanthocyanidin-lowering inhibitor of the epic catechins, a polyphenol composition containing the inhibitors, and Processed products containing polyphenols.
多酚係含於水果或蔬菜等各種植物中。一般已知攝取多酚有益於健康維持。 Polyphenols are contained in various plants such as fruits or vegetables. It is generally known that ingesting polyphenols is beneficial for healthy maintenance.
例如,可可亞包含可可亞多酚。可可亞多酚已知具有抗氧化作用、牙垢形成抑制作用、抗腫瘤作用、抗壓作用、癌症預防作用等各種生理效果。至於可可亞多酚之代表成分列舉為表兒茶素、兒茶素、原花青素(procyanidin)B2、原花青素B5、原花青素C1、桂皮鞣質(Cinnamtannin)A2等。 For example, cocoa contains cocoa polyphenols. Cocoa polyphenols are known to have various physiological effects such as anti-oxidation, tartar formation inhibition, anti-tumor action, anti-stress action, and cancer prevention. Representative components of cocoa polyphenols are epicatechin, catechin, procyanidin B2, proanthocyanidin B5, proanthocyanidin C1, Cinnamtannin A2 and the like.
另外,綠茶、紅茶、烏龍茶等茶類含豐富的茶多酚。茶多酚已知具有抗氧化活性、抗菌作用、抑制膽 固醇上升等之各種生理效果。茶多酚之代表性成分大致分成非表體兒茶素類與表體兒茶素類。非表體兒茶素類包含兒茶素、倍兒茶素(gallocatechin)、兒茶素沒食子酸酯(catechin gallate)、倍兒茶素沒食子酸酯(gallocatechin gallate)等。且,表體兒茶素類包含表兒茶素、表倍兒茶素、表兒茶素沒食子酸酯、表倍兒茶素沒食子酸酯等。 In addition, teas such as green tea, black tea, and oolong tea are rich in tea polyphenols. Tea polyphenols are known to have antioxidant activity, antibacterial action, and inhibit bile Various physiological effects such as sterol rise. Representative components of tea polyphenols are broadly classified into non-epidermal catechins and epiphytic catechins. Non-epidermal catechins include catechins, gallocatechin, catechin gallate, gallocatechin gallate, and the like. Further, the epicatechin catechins include epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate, and the like.
多酚已知會隨著pH值或因加熱之溫度變化而改變構造。例如,可可亞多酚中所含表兒茶素已知於萃取時係以(-)-表兒茶素存在,但在熱的水溶性溶液中經差向異構化成(-)-兒茶素。相對於此,作為使上述差向異構化最小化之方法,已提案有包含降低加熱溫度、降低pH及/或縮短加熱時間之方法(專利文獻1)。另外,關於茶多酚中所含各成分,已知在容器包裝茶飲料之製造步驟,尤其以溫水萃取茶葉之步驟或將萃取液充填於容器中後進行殺菌之步驟中,會引起天然型兒茶素類之異構化。相對於此,作為抑制上述天然型兒茶素類之異構化之方法,提案有將L-抗壞血酸添加於茶葉萃取液或萃取用水中,將茶萃取液之pH調節於5以下之後,進行加熱殺菌之方法(專利文獻2)。 Polyphenols are known to change structure with pH or temperature changes due to heating. For example, epicatechins contained in cocoa polyphenols are known to be present as (-)-epicatechin during extraction, but epimerized to (-)-catechin in a hot water-soluble solution. Prime. On the other hand, as a method of minimizing the above-described epimerization, a method of lowering the heating temperature, lowering the pH, and/or shortening the heating time has been proposed (Patent Document 1). Further, regarding the components contained in the tea polyphenol, it is known that the step of producing the tea beverage in the container, in particular, the step of extracting the tea leaves by warm water or the step of sterilizing after filling the extract in the container causes a natural type Isomerization of catechins. On the other hand, as a method of suppressing the isomerization of the natural catechins, it is proposed to add L-ascorbic acid to the tea extract or the extraction water, and adjust the pH of the tea extract to 5 or less, followed by heating. Method of sterilization (Patent Document 2).
專利文獻1:特表2008-544762號公報 Patent Document 1: Special Table 2008-544762
專利文獻2:特開2006-191851號公報 Patent Document 2: JP-A-2006-191851
非專利文獻1:J. Agric. Food Chem., Vol. 55 No. 23, 9559-9570, 2007 Non-Patent Document 1: J. Agric. Food Chem., Vol. 55 No. 23, 9559-9570, 2007
非專利文獻2:Biosci. Biotechnol. Biochem., Vol. 64 No. 12, 2581-2587, 2000 Non-Patent Document 2: Biosci. Biotechnol. Biochem., Vol. 64 No. 12, 2581-2587, 2000
非專利文獻3:J. Agric. Food Chem., Vol. 45 No. 12, 4624-4628, 1997 Non-Patent Document 3: J. Agric. Food Chem., Vol. 45 No. 12, 4624-4628, 1997
非專利文獻4:Food Chemistry 68(2000) Yinrong Lu, L. Yeap Foo「Antioxidant and radical scavenging activities of polyphenols from apple pomace」 Non-Patent Document 4: Food Chemistry 68 (2000) Yinrong Lu, L. Yeap Foo "Antioxidant and radical scavenging activities of polyphenols from apple pomace"
非專利文獻5:J. Agric. Food Chem., Vol. 25 No.6, 1268-1273, 1977 Non-Patent Document 5: J. Agric. Food Chem., Vol. 25 No. 6, 1268-1273, 1977
含有多酚之加工製品中,為了發揮多酚所具有之生理機能之效果,期望調配之多酚可安定的存在,且即使在加工製品中仍可維持其生理效果。 In the processed product containing polyphenols, in order to exert the physiological function of polyphenols, it is desirable that the formulated polyphenols can be stably present, and the physiological effects can be maintained even in the processed products.
然而,一般之飲食品等之加工製品製造時,在保存、加熱及殺菌等之處理步驟中,係應用pH4以上且37℃以上之溫度的條件。在該等條件下,多酚通常無法安 定的存在。例如,表體兒茶素類在pH4以上保存時,會差向異構化成非表體兒茶素類。且,原花青素類在pH4以上加熱及保存時,構造會產生變化,於檢測之加工製品中之總量會經時減低。 However, in the production of processed products such as general foods and drinks, conditions such as pH 4 or higher and 37 ° C or higher are applied in the treatment steps such as storage, heating, and sterilization. Under these conditions, polyphenols are usually not safe Definite existence. For example, when the epicatechin catechins are stored at a pH of 4 or higher, they are epimerized into non-epidermal catechins. Moreover, when the proanthocyanidins are heated and stored at pH 4 or higher, the structure changes, and the total amount in the processed product to be tested is reduced over time.
如專利文獻1及2所見,迄今為止所提案之多酚之安定化技術與pH、加熱溫度及加熱時間之條件的調節有關。依據此種過去之方法,加工製品之pH或其製造步驟中之處理條件變得受到限制。因此,要求以更簡便之方法使多酚安定化之手段。 As seen in Patent Documents 1 and 2, the stabilization technique of the polyphenol proposed so far is related to the adjustment of the conditions of pH, heating temperature, and heating time. According to this past method, the pH of the processed article or the processing conditions in the manufacturing steps thereof are limited. Therefore, a means for stabilizing polyphenols in a simpler manner is required.
本發明之一課題係關於提供有效使多酚安定化之安定化劑。尤其,本發明意圖提供在多酚之安定化中有效的安定化劑,作為抑制表體兒茶素類之差向異構化之手段及/或抑制原花青素類減低之手段。本發明之另一課題係關於含有上述多酚之安定化劑,且調配多酚後亦可安定地維持原有生理機能之含有多酚之組成物、及使用該組成物所構成之加工製品。 An object of the present invention is to provide a stabilizer for effectively stabilizing polyphenols. In particular, the present invention intends to provide a stabilizer which is effective in the stabilization of polyphenols, as means for inhibiting epimerization of epicatechins and/or means for suppressing reduction of proanthocyanidins. Another object of the present invention relates to a polyphenol-containing composition which contains a stabilizer of the above polyphenol and which can stably maintain the original physiological function after the preparation of the polyphenol, and a processed product comprising the composition.
本發明人等針對具有使多酚安定化效果之各種成分積極檢討。其結果,發現紅石榴萃取物等之植物萃取物對於多酚之安定化有用。尤其,紅石榴萃取物中豐富含有的鞣花酸(ellagic acid)及安石榴苷(punicalagin)對於多酚之安定化有顯著效果。本發明係基於該發現而完成者,為以如下所記載之事項為其特徵者。 The inventors of the present invention actively reviewed various components having an effect of stabilizing polyphenols. As a result, it was found that plant extracts such as red pomegranate extract are useful for the stabilization of polyphenols. In particular, ellagic acid and punicalagin, which are abundant in red pomegranate extract, have a significant effect on the stabilization of polyphenols. The present invention has been completed based on the findings, and is characterized by the matters described below.
(1)一種安定化劑,其為多酚之安定化劑,且包含鞣花酸及安石榴苷之至少一者。 (1) A stabilizer which is a stabilizer for polyphenols and which comprises at least one of ellagic acid and punica glucoside.
(2)如上述(1)所記載之安定化劑,其中以上述安定化劑之總重量為基準,至少上述鞣花酸之含量為15重量%以上,或上述安石榴苷之含量為30重量%以上。 (2) The stabilizer according to the above (1), wherein the content of at least the ellagic acid is 15% by weight or more based on the total weight of the stabilizer, or the content of the punica glucoside is 30% by weight. %the above.
(3)如上述(1)或(2)所記載之安定化劑,其中上述多酚安定化劑為表體兒茶素類之差向異構化抑制劑。 (3) The stabilizer according to the above (1) or (2), wherein the polyphenol stabilizer is an epimerization inhibitor of epicatechins.
(4)如上述(1)或(2)所記載之安定化劑,其中上述多酚安定化劑為原花青素類之降低抑制劑。 (4) The stabilizer according to the above (1) or (2), wherein the polyphenol stabilizer is a reduction inhibitor of proanthocyanidins.
(5)如上述(1)~(4)中任一項所記載之安定化劑,其中上述安定化劑為包含鞣花酸或安石榴苷之至少一者之植物萃取物。 The stabilizer of any one of the above-mentioned (1) to (4), wherein the stabilizer is a plant extract containing at least one of ellagic acid or punical glucoside.
(6)如上述(1)~(5)中任一項所記載之安定化劑,其中上述植物萃取物為紅石榴萃取物。 The stabilizer of any one of the above (1) to (5), wherein the plant extract is a red pomegranate extract.
(7)一種組成物,其包含多酚、與含鞣花酸及安石榴苷之至少一者之安定化劑。 (7) A composition comprising a polyphenol, and a stabilizer for at least one of ellagic acid and guaranuridine.
(8)如上述(7)所記載之組成物,其係含有如上述(1)~(6)中任一項所記載之安定化劑及多酚之組成物,其中相對於上述多酚100重量份,至少以使上述鞣花酸成為1.5重量份以上,或使上述安石榴苷成為5重量份以上之比例含有前述安定化劑。 The composition of the stabilizer according to any one of the above (1) to (6), wherein the composition of the polyphenol is 100% with respect to the above polyphenol 100. The stabilizer is contained in an amount of at least 1.5 parts by weight or more, or at least 5 parts by weight or more of the above ellagic acid.
(9)如上述(7)或(8)所記載之組成物,其中上述多酚為由原花青素類及兒茶素類所組成群組選出之至少一種。 (9) The composition according to the above (7) or (8), wherein the polyphenol is at least one selected from the group consisting of proanthocyanidins and catechins.
(10)如上述(7)~(9)中任一項所記載之組成物,其中上述安定化劑為包含鞣花酸或安石榴苷之至少一 者之植物萃取物。 (10) The composition according to any one of the above (7), wherein the stabilizer is at least one of ellagic acid or guaranol Plant extracts.
(11)如上述(7)~(10)中任一項所記載之組成物,其中上述植物萃取物為紅石榴萃取物。 (11) The composition according to any one of the above (7), wherein the plant extract is a red pomegranate extract.
(12)一種含有多酚之加工製品,其係使用如上述(7)~(11)中任一項所記載之組成物而構成之選自飲食品、醫藥品及化粧品所組成群組選出者。 (12) A processed product comprising a polyphenol, which is selected from the group consisting of food and beverage, pharmaceuticals, and cosmetics, which is composed of the composition according to any one of the above (7) to (11) .
(13)如上述(12)所記載之含有多酚之加工製品,其中上述含有多酚之加工製品之pH為4.0~8.0。 (13) The processed product containing polyphenols according to the above (12), wherein the polyphenol-containing processed product has a pH of 4.0 to 8.0.
(14)一種製造方法,其為含有多酚之加工製品的製造方法,其包含下列步驟:(a)調製如上述(7)~(11)中任一項所記載之組成物的步驟,(b)使用前述組成物,調製含有多酚之加工製品的步驟,(c)將前述含有多酚之加工製品加熱至37℃以上之溫度的步驟。 (14) A method for producing a processed article containing a polyphenol, comprising the steps of: (a) modulating the composition according to any one of the above (7) to (11), b) a step of preparing a processed article containing polyphenol using the above composition, and (c) a step of heating the processed article containing polyphenol to a temperature of 37 ° C or higher.
(15)一種含有多酚之加工製品,其係以如上述(14)所記載之製造方法製造之選自飲食品、醫藥品及化粧品所組成群組選出者。 (15) A processed product containing polyphenols, which is selected from the group consisting of foods, foods, pharmaceuticals, and cosmetics, which are produced by the production method described in the above (14).
(16)一種多酚之安定化方法,其係相對於多酚100重量份,至少以鞣花酸為1.5重量份以上,或安石榴苷為5重量份以上之比例共存。 (16) A method for the stabilization of polyphenols, which comprises at least 1.5 parts by weight or more of ellagic acid or 5 parts by weight or more of guaranuric acid based on 100 parts by weight of the polyphenol.
依據本發明,可提供在常識上多酚構造會變化之pH或溫度範圍中,可有效使多酚安定化之多酚安定 化劑。且,依據本發明,可提供藉由使上述安定化劑與多酚共存,而應用於加工製品中時可安定地保持多酚原有之生理機能之多酚組成物。且可提供使用上述組成物之飲食品、醫藥品及化粧品等各種含有多酚之加工製品。本發明之含有多酚之加工製品在其製造時可應用使用熱水之萃取處理及蒸餾(retort)殺菌處理,且以中性pH區域之液狀製品形態亦可長時間保存者。通常,在該種處理及保存條件下,已知會產生表體兒茶素類之差向異構化或原花青類之減少。然而,依據本發明,利用上述安定化劑,多酚可安定的維持調配時之狀態。 According to the present invention, it is possible to provide polyphenol stability which can effectively stabilize polyphenols in a pH or temperature range in which the polyphenol structure changes in common sense. Chemical agent. Further, according to the present invention, it is possible to provide a polyphenol composition which can stably maintain the physiological function of the polyphenol when it is applied to a processed product by allowing the stabilizer to coexist with the polyphenol. Further, various processed products containing polyphenols such as foods and drinks, pharmaceuticals, and cosmetics using the above composition can be provided. The processed product containing polyphenol of the present invention can be applied by extraction treatment using hot water and retort sterilization treatment, and can be stored for a long period of time in the form of a liquid product in a neutral pH region. In general, under such treatment and storage conditions, epimerization or proanthocyanidins of epiphytic catechins are known to be reduced. However, according to the present invention, with the above stabilizer, the polyphenol can be stably maintained in a state of being formulated.
本發明之揭示係關於2012年3月21日申請之特願2012-63334號之主題,該等說明書之揭示併入本說明書中供參考。 The disclosure of the present invention is the subject of Japanese Patent Application No. 2012-63334, the entire disclosure of which is incorporated herein by reference.
圖1為關於實施例1之圖表。該圖表係顯示由各種植物萃取物獲得之原花青素類減低抑制效果(加熱殺菌前後)。 FIG. 1 is a chart relating to Example 1. This chart shows the reduction inhibitory effect of proanthocyanidins obtained from various plant extracts (before and after heat sterilization).
圖2為關於實施例1之圖表。該圖表係顯示由各種植物萃取物獲得之差向異構化抑制效果(加熱殺菌前後)。 2 is a chart relating to Example 1. This chart shows the epimerization inhibition effect (before and after heat sterilization) obtained from various plant extracts.
圖3為關於實施例2之圖表。該圖表係顯示由各種植物萃取物獲得之原花青素類減低抑制效果(加溫保持中)。 Fig. 3 is a chart relating to Example 2. This chart shows the reduction inhibitory effect of proanthocyanidins obtained by various plant extracts (in warming retention).
圖4為關於實施例2之圖表。該圖表係顯示以各種植物萃取物獲得之差向異構化抑制效果(加溫保持中)。 4 is a graph relating to Example 2. This chart shows the epimerization inhibition effect (heating retention) obtained with various plant extracts.
圖5為關於實施例3之圖表。該圖表係顯示以紅石榴萃取物(鞣花酸含量90%)獲得之原花青素類減低抑制效果(加熱殺菌前後)。 Fig. 5 is a chart relating to Example 3. The graph shows the reduction inhibitory effect of proanthocyanidins obtained from red pomegranate extract (90% ellagic acid) (before and after heat sterilization).
圖6為關於實施例3之圖表。該圖表係顯示以紅石榴萃取物(鞣花酸含量90%)獲得之差向異構化抑制效果(加熱殺菌前後)。 Fig. 6 is a chart relating to Embodiment 3. The graph shows the epimerization inhibition effect (before and after heat sterilization) obtained from the pomegranate extract (90% ellagic acid content).
圖7為關於實施例3之圖表。該圖表係顯示以紅石榴萃取物(鞣花酸含量90%)獲得之原花青素類降低抑制效果(加溫保存中)。 Fig. 7 is a chart relating to Embodiment 3. The graph shows that the proanthocyanidins obtained by the red pomegranate extract (90% ellagic acid content) have a reduced inhibitory effect (in warm storage).
圖8為關於實施例3之圖表。該圖表係顯示以紅石榴萃取物(鞣花酸含量90%)獲得之差向異構化抑制效果(加溫保存中)。 Fig. 8 is a chart relating to Example 3. The graph shows the epimerization inhibition effect (in warm storage) obtained with red pomegranate extract (90% ellagic acid content).
圖9為關於實施例4之圖表。該圖表係顯示以各種紅石榴萃取物(鞣花酸含量15~40%,安石榴苷含量30%)獲得之原花青素類減低抑制效果(加熱殺菌前後)。 Fig. 9 is a chart relating to Example 4. The graph shows the reduction inhibitory effect of proanthocyanidins obtained before and after heat sterilization with various red pomegranate extracts (15-40% ellagic acid content, 30% guaranuric acid content).
圖10為關於實施例4之圖表。該圖表係顯示以各種紅石榴萃取物(鞣花酸含量15~40%,安石榴苷含量30%)獲得之差向異構化抑制效果(加熱殺菌前後)。 Fig. 10 is a chart relating to Example 4. The graph shows the epimerization inhibition effect (before and after heat sterilization) obtained from various red pomegranate extracts (15 to 40% ellagic acid content and 30% guaranuril content).
圖11關於實施例4之圖表。該圖表係顯示以紅石榴萃取物(鞣花酸含量40%)獲得之原花青素類減低抑制效果(加溫保存中)。 Figure 11 is a graph of Example 4. The graph shows the reduction inhibitory effect of proanthocyanidins obtained by extracting red pomegranate (40% ellagic acid) (in warm storage).
圖12為關於實施例4之圖表。該圖表係顯示以紅石 榴萃取物(鞣花酸含量40%)獲得之差向異構化抑制效果(加溫保存中)。 Figure 12 is a chart relating to Example 4. The chart shows the redstone The epimerization inhibitory effect (in warm storage) obtained from the extract of scent (40% ellagic acid).
圖13關於實施例4之圖表。該圖表係顯示以紅石榴萃取物(鞣花酸含量15%)獲得之原花青素類減低抑制效果(加溫保存中)。 Figure 13 is a chart of Example 4. The graph shows the reduction inhibitory effect of proanthocyanidins obtained by extracting red pomegranate (15% ellagic acid) (in warm storage).
圖14為關於實施例4之圖表。該圖表係顯示以紅石榴萃取物(鞣花酸含量15%)獲得之差向異構化抑制效果(加溫保存中)。 Figure 14 is a chart relating to Example 4. The graph shows the epimerization inhibition effect (in warm storage) obtained with red pomegranate extract (15% ellagic acid content).
圖15為關於實施例4之圖表。該圖表係顯示以紅石榴萃取物(安石榴苷含量30%)獲得之原花青素類減低抑制效果(加溫保存中)。 Figure 15 is a chart relating to Example 4. The graph shows the reduction inhibitory effect of proanthocyanidins obtained by extracting red pomegranate (30% guaranzol) (in warm storage).
圖16為關於實施例4之圖表。該圖表係顯示以紅石榴萃取物(安石榴苷含量30%)獲得之差向異構化抑制效果(加溫保存中)。 Figure 16 is a chart relating to Example 4. The graph shows the epimerization inhibition effect (in warm storage) obtained with red pomegranate extract (30% guaranol content).
圖17為關於實施例5之圖表。該圖表係顯示以鞣花酸純化品(試藥)及安石榴苷純化品(試藥)獲得之原花青素類減低抑制效果(加熱殺菌前後)。 Figure 17 is a chart relating to Example 5. The graph shows the reduction inhibitory effect of proanthocyanidins obtained by ellagic acid purified product (test drug) and purified pomegranate (test drug) (before and after heat sterilization).
圖18為關於實施例5之圖表。該圖表係顯示以鞣花酸純化品(試藥)及安石榴苷純化品(試藥)獲得之差向異構化抑制效果(加熱殺菌前後)。 Fig. 18 is a chart relating to Example 5. The graph shows the epimerization inhibition effect (before and after heat sterilization) obtained by ellagic acid purified product (test drug) and purified pomegranate product (test drug).
圖19為關於實施例5之圖表。該圖表係顯示以鞣花酸純化品(試藥)及安石榴苷純化品(試藥)獲得之原花青素類減低抑制效果(加溫保存中)。 Fig. 19 is a chart relating to Example 5. The graph shows the reduction inhibitory effect of proanthocyanidins obtained by purifying ellagic acid (test drug) and purified pomegranate (test drug) (in warm storage).
圖20為關於實施例5之圖表。該圖表係顯示以鞣花 酸純化品(試藥)及安石榴苷純化品(試藥)獲得之差向異構化抑制效果(加溫保存中)。 Figure 20 is a chart relating to Example 5. The chart shows the flower The effect of the isomerization inhibition obtained by the acid purified product (test drug) and the purified pomegranate product (test drug) (in warm storage).
圖21為關於實施例6之圖表。該圖表係顯示以鞣花酸純化品(試藥)獲得之兒茶素類之差向異構化抑制效果(加熱殺菌前後)。 Figure 21 is a chart relating to Example 6. This graph shows the epimerization inhibition effect (before and after heat sterilization) of catechins obtained by ellagic acid purified product (test drug).
圖22為關於實施例7之圖表。該圖表係顯示以各種濃度之鞣花酸純化品(試藥)獲得之兒茶素類之差向異構化抑制效果(加熱殺菌前後)。 Figure 22 is a chart relating to Example 7. This graph shows the epimerization inhibitory effect of catechins obtained before and after various concentrations of ellagic acid purified product (test drug) (before and after heat sterilization).
圖23為關於實施例7之圖表。該圖表係顯示以各種濃度之鞣花酸純化品(試藥)獲得之兒茶素類之差向異構化抑制效果(加溫保存中)。 Figure 23 is a chart relating to Example 7. This graph shows the epimerization inhibitory effect (in warm storage) of catechins obtained by purifying ellagic acid (test drug) at various concentrations.
圖24為關於實施例8之圖表。該圖表係顯示含有可可亞多酚之飲料(pH6.5)中之原花青素類減低抑制效果。 Figure 24 is a chart relating to Example 8. This graph shows the effect of reducing the inhibitory effect of proanthocyanidins in a beverage containing cocoa polyphenol (pH 6.5).
圖25為關於實施例8之圖表。該圖表係顯示含有可可亞多酚之飲料(pH6.5)中之差向異構化抑制效果。 Figure 25 is a chart relating to Example 8. This chart shows the epimerization inhibition effect in a beverage containing cocopolyphenol (pH 6.5).
圖26為關於比較例1之圖表。該圖表係顯示以沒食子酸獲得之原花青素類減低抑制效果之試驗結果。 Fig. 26 is a chart regarding Comparative Example 1. This chart shows the results of the test for reducing the inhibitory effect of proanthocyanidins obtained by gallic acid.
圖27為關於比較例1之圖表。該圖表係顯示以沒食子酸獲得之差向異構化抑制效果之試驗結果。 Fig. 27 is a chart regarding Comparative Example 1. This chart shows the test results of the epimerization inhibition effect obtained with gallic acid.
圖28為關於參考例1之圖表。該圖表係顯示各種植物萃取物之抗氧化活性與原花青素類殘留率之關係。 28 is a graph relating to Reference Example 1. This chart shows the relationship between the antioxidant activity of various plant extracts and the residual rate of proanthocyanidins.
圖29為關於參考例1之圖表。該圖表係顯示各種植物萃取物之總多酚量與原花青素類殘留率之關係。 29 is a graph relating to Reference Example 1. This chart shows the relationship between the total amount of polyphenols in various plant extracts and the residual rate of proanthocyanidins.
以下針對本發明之細節加以說明。 The details of the invention are described below.
〈安定化劑〉 <安定化剂>
本發明之第一樣態為多酚之安定化劑,其特徵為包含鞣花酸及安石榴苷之至少一種。詳情如下。 The first aspect of the present invention is a polyphenol stabilizer which is characterized by comprising at least one of ellagic acid and punica glucoside. Details are as follows.
(鞣花酸) (Ellagic acid)
本發明之所謂「鞣花酸」意指以如下(化1)之構造式表示之物質。 The term "ellaric acid" as used in the present invention means a substance represented by the following structural formula (Chemical Formula 1).
(安石榴苷) (an pomegranate)
本發明之所謂「安石榴苷」係指以如下(化2)之構造式表示之物質。安石榴苷為紅石榴等植物中所含之鞣花單寧(ellagitannin)之一種。鞣花單寧為具有六羥基二沒食子醯基(hexahydroxydiphenoyl)之水解型單寧類。鞣 花單寧經酸分解時生成鞣花酸。 The "anatillin" of the present invention means a substance represented by the following structural formula (Chemical Formula 2). Angina is a kind of ellagitannin contained in plants such as red pomegranate. Thistle tannin is a hydrolyzed tannin having hexahydroxydiphenoyl.鞣 Flower tannins produce ellagic acid upon acid decomposition.
(安定化劑) (anti-setting agent)
本發明之安定化劑包含上述鞣花酸及上述安石榴苷之至少一種作為有效成分。雖並未特別限制,但本發明之一實施形態中,以上述安定化劑之總重量為基準,上述鞣花酸之含量較好為15重量%以上。且,以上述安定化劑之總重量為基準,上述安石榴苷之含量較好為30重量%以上。上述安定化劑以上述含量範圍含有鞣花酸及安石榴苷之至少一種時,藉由上述安定化劑可使多酚安定化變得容易。另外,本發明之安定化劑亦可混合存在鞣花酸與安石榴苷,其比率並無特別限制。本發明之安定化劑只要不對由上述各成分獲得之效果造成實質之影響即無特別限制,亦可包含本技藝者習知之其他各種成分。 The stabilizer of the present invention contains at least one of the above ellagic acid and the above-mentioned punica glucoside as an active ingredient. Although it is not particularly limited, in one embodiment of the present invention, the content of the ellagic acid is preferably 15% by weight or more based on the total weight of the stabilizer. Further, the content of the punny glucoside is preferably 30% by weight or more based on the total weight of the stabilizer. When the stabilizer is contained in at least one of ellagic acid and punical glucoside in the above content range, the stabilization of the polyphenol can be facilitated by the stabilizer. Further, the stabilizer of the present invention may be mixed with ellagic acid and punical glucoside, and the ratio thereof is not particularly limited. The stabilizer of the present invention is not particularly limited as long as it does not substantially affect the effects obtained by the above respective components, and may include other various components conventionally known to those skilled in the art.
上述鞣花酸及上述安石榴苷已知存在於果實等許多植物中。含豐富鞣花酸之植物列舉為例如紅石榴、 草莓、覆盆子(raspberry)、蔓越莓(cranberry)、葡萄、栗子、胡桃等。亦可使用含有鞣花酸及安石榴苷之至少一種之植物萃取物作為本發明之安定化劑。例如,本發明之安定化劑可使用紅石榴萃取物、草莓萃取物、覆盆子萃取物、蔓越莓萃取物、葡萄萃取物、栗子萃取物、胡桃萃取物之植物萃取物。最好列舉為紅石榴萃取物。上述植物萃取物宜為果汁或濃縮果汁。本發明之一實施形態可使用含有鞣花酸及安石榴苷之至少一者之市售紅石榴萃取物作為安定化劑。例如,作為本發明之安定化劑之一實施形態,列舉為NATURAX製造之紅石榴萃取物(含有鞣花酸40%)、日本BIO ACTIVES製造之紅石榴萃取物(含有鞣花酸90%以上)、ARJUNA製造之紅石榴萃取物(水解後之鞣花酸含有15~20%)、OMNICA製造之Pomella(註冊商標)(含有安石榴苷30%以上)。 The above ellagic acid and the above-mentioned punical guava are known to exist in many plants such as fruits. Plants rich in ellagic acid are listed, for example, as red pomegranate. Strawberries, raspberries, cranberries, grapes, chestnuts, walnuts, etc. A plant extract containing at least one of ellagic acid and punica glucoside may also be used as the stabilizer for the present invention. For example, the stabilizer of the present invention may use a plant extract of red pomegranate extract, strawberry extract, raspberry extract, cranberry extract, grape extract, chestnut extract, and walnut extract. Preferably listed as red pomegranate extract. The above plant extract is preferably a juice or a concentrated juice. In one embodiment of the present invention, a commercially available red pomegranate extract containing at least one of ellagic acid and guaranurin can be used as a stabilizer. For example, as an embodiment of the stabilizer of the present invention, a red pomegranate extract (containing 40% of ellagic acid) manufactured by NATURAX and a pomegranate extract (containing 90% or more of ellagic acid) manufactured by BIO ACTIVES of Japan are listed. , the red pomegranate extract made by ARJUNA (15-20% of ellagic acid after hydrolysis), Pomella (registered trademark) by OMNICA (containing more than 30% of pomegranate).
本發明中,作為上述安定化劑,除上述植物萃取物以外,亦可使用鞣花酸及/或安石榴苷之純化品。上述純化品可為根據習知方法,將上述植物萃取物之鞣花酸或安石榴苷之濃度提高至90~100重量%者。又,上述純化品亦可為作為試藥銷售之鞣花酸或安石榴苷。亦即,本發明中,可使用鞣花酸純化品、安石榴苷純化品、以及較好為紅石榴萃取物的含有鞣花酸及安石榴苷之至少一者之植物萃取物所組成群組選出之一種以上作為安定化劑。 In the present invention, as the stabilizer, a purified product of ellagic acid and/or punical glucoside may be used in addition to the above plant extract. The above purified product may be one in which the concentration of ellagic acid or punical glucoside of the above plant extract is increased to 90 to 100% by weight according to a conventional method. Further, the purified product may be ellagic acid or punical glucoside which is sold as a reagent. That is, in the present invention, a group consisting of a purified product of ellagic acid, a purified pomegranate, and a plant extract containing at least one of ellagic acid and guaranuric acid, preferably a red pomegranate extract, may be used. One or more selected ones are used as stabilizers.
本發明之安定化劑之一實施形態中,以該安 定化劑之總重量為基準,鞣花酸之含量為15~100重量%,較好為30~100重量%,更好為40~100重量%,最好為90~100重量%之範圍。本發明之安定化劑之另一實施形態中,安石榴苷之含量為30~100重量%,較好為40~100重量%,更好為80~100重量%。且,本發明之安定化劑之另一實施形態中,以總安定化劑之重量為基準,鞣花酸之含量為15~100重量%時,安石榴苷係以85~0重量%之範圍之任意比例存在。且,同樣地,安石榴苷之含量為30~100重量%時,鞣花酸係以70~0重量%之範圍之任意比例存在。 In one embodiment of the stabilizer of the present invention, The content of ellagic acid is from 15 to 100% by weight, preferably from 30 to 100% by weight, more preferably from 40 to 100% by weight, most preferably from 90 to 100% by weight, based on the total weight of the tempering agent. In another embodiment of the stabilizer of the present invention, the content of guavaside is 30 to 100% by weight, preferably 40 to 100% by weight, more preferably 80 to 100% by weight. Further, in another embodiment of the stabilizer of the present invention, when the content of ellagic acid is 15 to 100% by weight based on the weight of the total stabilizer, the guaranol is in the range of 85 to 0% by weight. Any ratio exists. Further, similarly, when the content of punical guavaside is 30 to 100% by weight, the ellagic acid is present in an arbitrary ratio in the range of 70 to 0% by weight.
本發明之安定化劑之形態並無限制,可為液體、粉末、顆粒等之任一種。 The form of the stabilizer of the present invention is not limited, and may be any of liquid, powder, granules and the like.
(多酚) (polyphenol)
本發明中所謂“多酚”意指具有於苯環上存在兩個以上羥基之構造之化合物。然而,上述多酚不含於本發明中作為安定化劑使用之鞣花酸及安石榴苷。多酚分成簡單酚類(simple phenols)、類黃酮(flavonoid)類、水解型單寧(tannin)類、縮合型單寧類(花青素原(proanthocyanidin)類)。上述簡單酚類之一例列舉為二羥基酸、羥基咖啡酸衍生物類。上述類黃酮類之一例列舉為黃酮類、黃酮醇(flavonol)類、異黃酮類、黃烷(flavan)類、黃烷醇(兒茶素)類、黃烷酮類、黃烷酮醇(flavanonol)類、查耳酮(chalcone)類、花青素 (anthocyanidin)類。尤其,上述兒茶素類之一例,列舉為兒茶素、表兒茶素。上述水解型單寧類為上述簡單酚類之聚合物,縮合型單寧類(原花青素類)為上述類黃酮類之聚合物。尤其,上述花青素原類之一例列舉為原花青素類。 The term "polyphenol" as used in the present invention means a compound having a structure in which two or more hydroxyl groups are present on a benzene ring. However, the above polyphenol does not contain ellagic acid and punical glucoside as a stabilizer in the present invention. Polyphenols are classified into simple phenols, flavonoids, hydrolyzed tannins, and condensed tannins (proanthocyanidins). An example of the above simple phenols is exemplified by dihydroxy acids and hydroxycaffeic acid derivatives. One example of the above flavonoids is flavonoids, flavonols, isoflavones, flavans, flavanols (catechins), flavanones, flavanones (flavanonol). ), chalcone, anthocyanins (anthocyanidin) class. In particular, an example of the above catechins is catechin and epicatechin. The hydrolyzed tannins are polymers of the above simple phenols, and the condensed tannins (proanthocyanidins) are polymers of the above flavonoids. In particular, one of the above anthocyanins is exemplified by proanthocyanidins.
雖未特別限制,但本發明之一實施形態中,上述多酚較好為由原花青素類及兒茶素類所組成群組選出之至少一種。更具體而言,以可可亞多酚及茶多酚較佳,以可可亞多酚最佳。上述可可亞多酚係由可可亞原料所得之原花青素類。另一方面,上述茶多酚係由茶原料所得之兒茶素類。 Although it is not particularly limited, in one embodiment of the present invention, the polyphenol is preferably at least one selected from the group consisting of proanthocyanidins and catechins. More specifically, cocopolyphenol and tea polyphenol are preferred, and cocoa polyphenol is preferred. The above-mentioned cocoa polyphenol is a proanthocyanidin obtained from a raw material of cocoa. On the other hand, the above tea polyphenols are catechins obtained from tea raw materials.
(多酚之安定化) (stabilization of polyphenols)
本發明中所謂“多酚之安定化”意指抑制因pH或熱產生之上述多酚之構造變化。更具體而言,意指對於應用在pH4.0以上,更詳言之於pH4.0以上且37℃以上之條件之保存、加熱及殺菌等之加工條件,本發明之安定化劑抑制了多酚之構造變化,而可使多酚維持初期狀態。上述構造變化可利用例如表體兒茶素類中差向異構物比率之變化以及原花青素類之檢測量之減低予以確認。本發明之安定化劑之作用機制詳情尚不明確,但推測為上述安定化劑以差向亦構化抑制劑作用時,上述安定化劑可以使上述多酚化合物維持為初期之立體配位子之方式發揮作用。 The "stabilization of polyphenols" in the present invention means to suppress the structural change of the above polyphenols due to pH or heat. More specifically, it means that the stabilizer of the present invention inhibits the processing conditions such as storage, heating and sterilization which are applied at a pH of 4.0 or higher, more specifically, at a pH of 4.0 or more and 37 ° C or more. The structural changes of the phenol can maintain the polyphenols in an initial state. The above structural change can be confirmed by, for example, a change in the ratio of the epimers in the epicatechin catechins and a decrease in the amount of detection of the proanthocyanidins. The details of the mechanism of action of the stabilizer of the present invention are not clear, but it is presumed that the stabilizer can maintain the polyphenol compound as an initial stereospecific ligand when the stabilizer is acted as a differential conformation inhibitor. The way it works.
(兒茶素類) (catechins)
本發明中記載之上述“兒茶素類”為表體兒茶素類與非表體兒茶素類之總稱。上述“表體兒茶素類”之具體例,舉例有表兒茶素、表沒食子兒茶素(epigallocatechin)及表沒食子兒茶素沒食子酸酯。且“非表體兒茶素類”之具體例,舉例有兒茶素、沒食子兒茶素及沒食子兒茶素沒食子酸酯。 The above-mentioned "catechins" described in the present invention are a general term for epicatechin catechins and non-epitopic catechins. Specific examples of the above-mentioned "epidermal catechins" include epicatechin, epigallocatechin, and epigallocatechin gallate. Specific examples of the "non-epidermal catechins" include catechins, gallocatechin, and gallocatechin gallate.
(表體兒茶素類之差向異構化抑制) (Inhibition of epimerization of epigenetic catechins)
已知上述之表體兒茶素類在pH4.0以上之條件下,會引起差向異構化,而變化成非表體兒茶素類。例如,於pH4.0以上之條件下,可可亞多酚等中所含之(-)-表兒茶素差向異構化為(-)-兒茶素。同樣地,茶萃取物中所含之(-)-表沒食子兒茶素表沒食子酸酯差向異構化為(-)-沒食子兒茶素表沒食子酸酯。再者,分別係表沒食子酸兒茶素差向異構化為沒食子兒茶素,表兒茶素沒食子酸酯差向異構化為兒茶素沒食子酸酯。相對於此,藉由使本發明之安定化劑與上述表體兒茶素類共存,可有效地抑制上述差向異構化。 It is known that the above-mentioned epigenetic catechins cause epimerization and change to non-epithelial catechins under the conditions of pH 4.0 or higher. For example, under conditions of pH 4.0 or higher, (-)-epicatechin contained in cocoapolyphenol or the like is epimerized to (-)-catechin. Similarly, the (-)-epigallocatechin gallate-containing gallate contained in the tea extract is epimerized to (-)-gallocatechin gallate. Furthermore, epigallocatechin is separately epimerized to gallocatechin, and epicatechin gallate is epimerized to catechin gallate. On the other hand, by allowing the stabilizer of the present invention to coexist with the epicatechin catechin, the epimerization can be effectively suppressed.
雖未特別限制,但本發明之一實施形態,以安定化劑之總重量為基準,藉由使用含有15重量%以上之鞣花酸之安定化劑,對於可可亞多酚之差向異構化抑制以及茶多酚之差向異構化抑制任一者,均可獲得良好結果。且,以安定化劑之重量為基準,藉由使用含有30重 量%以上安石榴苷之安定化劑,對於可可亞多酚之差向異構化抑制可獲得良好結果。 Although not particularly limited, in one embodiment of the present invention, the isomerization of cocoa polyphenols is carried out by using a stabilizer of 15% by weight or more of ellagic acid based on the total weight of the stabilizer. Both the inhibition of the inhibition and the inhibition of the isomerization of the tea polyphenol can give good results. And, based on the weight of the stabilizer, by using 30 weights A stabilizer of more than 5% of pomegranate can obtain good results for the inhibition of epimerization of cocoa polyphenol.
(原花青素類) (original anthocyanins)
本發明中之所謂“原花青素”意指具有以類黃酮類之基本骨架聚合之構造的物質。原花青素包含於可可亞、葡萄種子、葡萄皮、蘋果、松之樹皮等中。可可亞多酚中所含之代表性原花青素舉例有原花青素B2、原花青素B5、原花青素C1、桂皮鞣質A2等。本發明中所記載之“原花青素類”包含由表兒茶素、兒茶素、原花青素B2、原花青素B5、原花青素C1、桂皮鞣質A2所成之合計6成分。 The term "proanthocyanidin" in the present invention means a substance having a structure in which a basic skeleton of flavonoids is polymerized. Proanthocyanidins are contained in cocoa, grape seeds, grape skins, apples, pine bark, and the like. Representative proanthocyanidins contained in cocoa polyphenols include proanthocyanidin B2, proanthocyanidin B5, proanthocyanidin C1, cassia tannin A2, and the like. The "proanthocyanidins" described in the present invention comprise a total of 6 components derived from epicatechin, catechin, proanthocyanidin B2, proanthocyanidin B5, proanthocyanidin C1, and cinnabarin A2.
(原花青素類之減低抑制) (Reduction inhibition of proanthocyanidins)
上述原花青素類會因在pH4.0以上之條件下,更詳言之於pH4.0以上且37℃以上之溫度條件之加熱及保存而減少。然而,藉由使本發明之安定化劑與上述原花青素類共存,可有效地抑制上述原花青素類之減低。 The proanthocyanidins are reduced by heating and storage under conditions of pH 4.0 or higher, more specifically pH 4.0 or higher and 37 ° C or higher. However, by allowing the stabilizer of the present invention to coexist with the proanthocyanidins, the reduction of the proanthocyanidins can be effectively suppressed.
<含安定化劑之組成物> <Composition containing stabilizers>
本發明之第二樣態係關於含有多酚與鞣花酸及安石榴苷之至少一者之安定化劑之組成物。亦即,本發明之多酚組成物之特徵為包含含有多酚之原材料以及本發明第一樣態之安定化劑。本發明之一實施形態中,上述安定化劑可為包含鞣花酸及安石榴苷之至少一者之植物萃取物,較好 為紅石榴萃取物。且,另一實施形態中,上述安定化劑亦可為鞣花酸純化品及安石榴苷純化品。 A second aspect of the present invention relates to a composition comprising a stabilizer of at least one of polyphenols, ellagic acid and punical guava. That is, the polyphenol composition of the present invention is characterized by comprising a raw material containing a polyphenol and a stabilizer of the first aspect of the present invention. In one embodiment of the present invention, the stabilizer may be a plant extract containing at least one of ellagic acid and punical glucoside, preferably For red pomegranate extract. Furthermore, in another embodiment, the stabilizer may be a purified ellagic acid product or a purified product of punica glucoside.
本發明之組成物中,上述安定化劑之使用量並未特別限制。然而,一實施形態中,相對於多酚100重量份,至少以上述鞣花酸成為1.5重量份以上、或上述安石榴苷成為5重量份以上之比例,調配上述安定化劑。如由後述之實施例所明瞭,藉由以上述比例使用安定化劑,變得容易使組成物中之多酚安定地維持。上述多酚較好為由原花青素類及兒茶素類所組成群組選擇之一種以上。更具體而言,較好為可可亞多酚及/或茶多酚,最好為可可亞多酚。且,本發明之組成物只要不對多酚之安定化效果帶來實質影響,則可含本技藝者公知之其他各種成分。本發明之多酚組成物可使用作為食品添加物等之加工製品的原料,或其本身可使用作為食品等之加工製品。 In the composition of the present invention, the amount of the stabilizer to be used is not particularly limited. However, in one embodiment, the stabilizer is blended in an amount of at least 1.5 parts by weight or more of the ellagic acid or 5 parts by weight or more based on 100 parts by weight of the polyphenol. As will be understood from the examples described later, by using the stabilizer in the above ratio, it is easy to maintain the polyphenol in the composition stably. The polyphenol is preferably one or more selected from the group consisting of proanthocyanidins and catechins. More specifically, it is preferably cocopolyphenol and/or tea polyphenol, preferably cocopolyphenol. Further, the composition of the present invention may contain other various components known to those skilled in the art as long as it does not substantially affect the stabilization effect of the polyphenol. The polyphenol composition of the present invention can be used as a raw material of a processed product such as a food additive, or can be used as a processed product such as a food.
依據本發明之組成物,於在pH4.0以上之加工製品或在37℃以上之溫度施以加熱處理之加工製品中,調配該等組成物時,亦可對加工製品賦予多酚本來之生理機能。且,依據上述組成物,在加工或保存後自可安定地維持上述加工前之多酚狀態。 According to the composition of the present invention, in a processed product having a pH of 4.0 or higher or a processed product which is subjected to heat treatment at a temperature of 37 ° C or higher, when the composition is formulated, the physiological property of the polyphenol can be imparted to the processed product. function. Further, according to the above composition, the polyphenol state before the above processing can be maintained stably after processing or storage.
<含多酚之加工製品> <Processed Products Containing Polyphenols>
本發明之第三樣態係有關含有多酚與鞣花酸及安石榴苷之至少一者之安定化劑的含多酚加工製品。至於上述加工製品之具體例,舉例為飲食品、醫藥品、化粧品。雖未 特別限制,但本發明之一實施形態中,上述加工製品較好為飲食品。其中較好為飲料,最好為容器包裝飲料。 A third aspect of the present invention relates to a polyphenol-containing processed article comprising a stabilizer of at least one of polyphenols, ellagic acid and punical guava. Specific examples of the above processed products include foods and drinks, pharmaceuticals, and cosmetics. Not yet In particular, in one embodiment of the present invention, the processed product is preferably a food or beverage. Among them, beverages are preferred, and beverages are preferably packaged in containers.
上述加工製品可使用本發明第二樣態之前述記載之多酚組成物維原料或為原料之一部份而構成。亦即,本發明之加工製品之實施形態中,依據所希望之加工製品形態,可刻意使上述組成物含有追加成分。如此之實施形態中,上述安定化劑之使用量並未特別限制。然而,本發明之一實施形態中,較好相對於多酚100重量份,至少以上述鞣花酸成為1.5重量份以上、或上述安石榴苷成為5重量份以上之比例,調配上述安定化劑。藉由以上述比例使用上述安定化劑,變得容易使加工製品中之多酚安定地維持。另一方面,上述安定化劑之調配量上限並無特別限制,只要考慮口味、香味及成本予以設定即可。例如,相對於加工製品中所含之多酚100重量份,可以鞣花酸成為1.5~350重量份,及/或安石榴苷成為5~350重量份之比例調配於加工製品中。 The processed product may be formed by using the polyphenol composition of the second aspect of the present invention as a raw material or as a part of the raw material. That is, in the embodiment of the processed product of the present invention, the composition may be intentionally made to contain an additional component depending on the desired form of the processed product. In such an embodiment, the amount of the stabilizer to be used is not particularly limited. However, in one embodiment of the present invention, it is preferred to blend the above stabilizer with at least 1.5 parts by weight or more of the ellagic acid or 5 parts by weight or more of the guaiac acid in an amount of at least 100 parts by weight of the polyphenol. . By using the above stabilizer in the above ratio, it becomes easy to stably maintain the polyphenol in the processed product. On the other hand, the upper limit of the amount of the stabilizer is not particularly limited, and may be set in consideration of taste, flavor, and cost. For example, it may be blended in the processed product in an amount of from 1.5 to 350 parts by weight, and/or from 5 to 350 parts by weight of guaranuric acid, based on 100 parts by weight of the polyphenol contained in the processed product.
(飲食品) (food and drink)
以下,以飲食品作為本發明之加工製品之一例加以具體說明。上述飲食品包含多酚及上述安定化劑,其他為本技藝者周知之成分。飲食品之具體例舉例為飲料、可可亞、咖啡、口香糖、軟糖、果凍、羊羹、SHERPET、乳製品。上述飲食品之形態並未特別限制,但較好為含水量高的食品、或容器包裝後具有加熱殺菌過程之飲料或食品。 上述食品之含水量較好為10重量%以上。 Hereinafter, foods and drinks will be specifically described as an example of the processed product of the present invention. The food and beverage products include polyphenols and the above-mentioned stabilizers, and others are well known to those skilled in the art. Specific examples of the food and drink are, for example, beverages, cocoa, coffee, chewing gum, soft candy, jelly, alpaca, SHERPET, and dairy products. The form of the food or drink is not particularly limited, but is preferably a food having a high water content or a beverage or food having a heat sterilization process after the container is packaged. The water content of the above food is preferably 10% by weight or more.
上述飲食品之pH並未限定。然而,已知在pH4.0以上時,會引起表體兒茶素類之差向異構化或安石榴苷類減少之不期望現象。且,已知因加熱會促進該等現象。然而,依據本發明,利用加工製品中之上述安定化劑,可有效地抑制上述不期望現象。因此,本發明之加工製品之pH可為4.0以上。由此種上述安定化劑之安定化效果之觀點而言,上述飲食品之pH較好在4.0~8.0,更好為4.0~7.5,又更好為5.5~6.5之範圍。 The pH of the above foods and drinks is not limited. However, it is known that when pH is 4.0 or more, it causes an undesirable phenomenon of epimerization of epicatechin catechins or reduction of pomegranate. Moreover, it is known that such phenomena are promoted by heating. However, according to the present invention, the above-mentioned undesired phenomenon can be effectively suppressed by using the above-mentioned stabilizer in the processed product. Therefore, the pH of the processed article of the present invention may be 4.0 or more. From the viewpoint of the stabilization effect of the above-mentioned stabilizer, the pH of the food or beverage is preferably from 4.0 to 8.0, more preferably from 4.0 to 7.5, still more preferably from 5.5 to 6.5.
再者,上述飲食品亦可為具有上述範圍之pH且經過於37℃以上之溫度加熱之步驟所製造者。尤其,上述飲食品可為經過於120℃以上之溫度加熱殺菌之步驟所製造者。又,上述所謂“於37℃以上之溫度加熱之步驟”不僅包含飲食品製造時,亦包含飲食品流通時在37℃以上保存及銷售之步驟。 Further, the food or beverage may be one which has a pH in the above range and is heated at a temperature of 37 ° C or higher. In particular, the food or beverage may be produced by a step of heat sterilization at a temperature of 120 ° C or higher. In addition, the above-mentioned "step of heating at a temperature of 37 ° C or higher" includes not only the production of foods and drinks, but also the step of storing and selling the food and beverage at 37 ° C or higher.
本發明中,上述飲食品中之多酚含量並未特別限制。通常,飲食品中多酚含量係以可發揮目的之生理機能效果之方式加以設定。因此,本發明中,只要設定飲食品中之多酚含量後,再決定上述安定化劑之使用量即可。例如,上述安定化劑相對於上述多酚含量100重量份,至少以鞣花酸成為1.5重量份以上,或安石榴苷成為5重量份以上之比例調配即可。 In the present invention, the polyphenol content in the above foods and drinks is not particularly limited. In general, the polyphenol content in foods and drinks is set in such a manner that the physiological function of the object can be exerted. Therefore, in the present invention, the amount of the stabilizer to be used may be determined by setting the amount of the polyphenol in the food or beverage. For example, the stabilizer may be formulated in an amount of at least 1.5 parts by weight of ellagic acid or 5 parts by weight or more of guaiac with respect to 100 parts by weight of the polyphenol content.
上述飲食品例如可依據下述(i)~(iii)之方法製造。(i)飲料之調製:調配28.5mg~100mg之多酚、 0.5mg~100mg之安定化劑以及依據需要追加之本技藝中公知之成分,而調製100ml之飲料。此處,上述多酚亦可為例如原花青素類、兒茶素類。且上述安定化劑亦可為例如鞣花酸純化品、安石榴苷純化品、或至少以上述安定化劑總重量為基準含有15重量%以上之鞣花酸及30重量%以上之安石榴苷之至少一者之紅石榴萃取物之任一者。且上述公知成分,宜為作為一般飲食品之原材料或添加物使用之原材料。例如,上述飲料品中亦可含有水、糖類、糖醇類、澱粉及加工澱粉、食物纖維、牛乳、加工乳、豆奶、果汁、蔬果汁、水果蔬菜及其加工品、蛋白質、胜肽、胺基酸類、動物及植物草藥萃取物、來自天然之高分子(膠原、玻尿酸、軟骨素等)、維他命類、礦物質類、增黏劑、乳化劑、保存劑、著色劑、香料等。 The food or drink can be produced, for example, according to the methods (i) to (iii) below. (i) Preparation of beverages: blending 28.5mg~100mg polyphenols, A 100 ml beverage is prepared by adding 0.5 mg to 100 mg of the stabilizer and the ingredients known in the art as needed. Here, the polyphenol may be, for example, a proanthocyanidin or a catechin. Further, the stabilizer may be, for example, a purified ellagic acid product, a purified pomegranate, or at least 15% by weight of ellagic acid and 30% by weight or more of guaranuric acid based on the total weight of the stabilizer. Any of the red pomegranate extracts of at least one of them. Further, the above-mentioned known component is preferably a raw material used as a raw material or an additive of a general food or beverage. For example, the beverage product may also contain water, sugar, sugar alcohol, starch and processed starch, dietary fiber, milk, processed milk, soy milk, juice, vegetable juice, fruits and vegetables and processed products, protein, peptide, amine Base acid, animal and plant herbal extracts, natural polymers (collagen, hyaluronic acid, chondroitin, etc.), vitamins, minerals, tackifiers, emulsifiers, preservatives, colorants, perfumes, etc.
(ii)飲料之pH調整:將如上述調製之飲料之pH調整至5.5~6.5之範圍。調整時,依據需要,亦可使用有機酸及其鹽類、酸味劑或pH調整劑。更詳言之,亦於上述飲料中添加蘋果酸及其鹽類、檸檬酸及其鹽類、酒石酸及其鹽類、乳酸及其鹽類、磷酸及其鹽類、碳酸鈣、碳酸氫鈉、碳酸鈉等。 (ii) pH adjustment of the beverage: The pH of the beverage prepared as described above was adjusted to a range of 5.5 to 6.5. When adjusting, organic acids and their salts, sour agents or pH adjusters may also be used as needed. More specifically, malic acid and its salts, citric acid and its salts, tartaric acid and its salts, lactic acid and its salts, phosphoric acid and its salts, calcium carbonate and sodium hydrogencarbonate are also added to the above beverages. Sodium carbonate and the like.
(iii)飲料之加熱殺菌:將pH經調整之上述飲料封入密閉容器中,在例如121℃之溫度條件下加熱殺菌歷時10分鐘。 (iii) Heat sterilization of the beverage: The pH-adjusted beverage is sealed in a closed container and heat-sterilized at a temperature of, for example, 121 ° C for 10 minutes.
(其他加工製品) (Other processed products)
以上,針對本發明之加工製品之實施形態,以飲食品為例加以說明。然而,依據本發明,使用包含多酚與含有鞣花酸及安石榴苷之至少一者之安定化劑之組成物,亦可構成醫藥品(包含準醫藥品)或化粧品之其他加工製品。構成醫藥品作為加工製品時,上述醫藥品除上述成分以外,亦包含本技藝者周知之成分。例如,本發明之一實施形態中,上述醫藥品宜包含多酚、上述安定化劑、醫藥品藥效成分、不屬於藥事法上之醫藥品或準醫藥品之醫藥品製劑中所含有效成分以外之物質。上述物質之具體例舉例有賦形劑、崩解劑、結合劑、流動化劑、矯味劑、香料、著色劑、甜味劑、溶劑、油脂、增黏劑、界面活性劑、膠凝化劑、安定劑、保存劑、緩衝劑、懸浮劑、黏稠劑等。醫藥品之形態並未特別限定。基於與上述飲食品同樣之觀點,上述醫藥品之pH亦可為4.0以上。由上述安定化劑之安定化效果之觀點而言,上述醫藥品之pH為4.0~8.0,更好為pH4.0~7.5,更好為pH5.5~6.5之範圍。又,上述醫藥品亦可為經過於37℃以上加熱之步驟而製造者。 As described above, the food and beverage product will be described as an example of the embodiment of the processed product of the present invention. However, according to the present invention, a composition comprising a polyphenol and a stabilizer containing at least one of ellagic acid and guaranuric acid may be used to constitute a pharmaceutical product (including a quasi-drug) or other processed product of the cosmetic. In the case of constituting a pharmaceutical product as a processed product, the above-mentioned pharmaceutical product contains components well known to those skilled in the art in addition to the above components. For example, in one embodiment of the present invention, the pharmaceutical product preferably contains a polyphenol, the stabilizer, a pharmaceutical medicinal ingredient, and a pharmaceutical preparation that is not a pharmacy drug or a quasi-drug. Substances other than ingredients. Specific examples of the above substances include excipients, disintegrators, binders, fluidizers, flavoring agents, perfumes, colorants, sweeteners, solvents, fats and oils, tackifiers, surfactants, and gelling agents. , stabilizers, preservatives, buffers, suspending agents, thickeners, etc. The form of the pharmaceutical product is not particularly limited. The pH of the above pharmaceutical product may be 4.0 or more based on the same viewpoint as the above-mentioned food and drink. The pH of the above-mentioned pharmaceutical product is from 4.0 to 8.0, more preferably from pH 4.0 to 7.5, more preferably from pH 5.5 to 6.5, from the viewpoint of the stabilization effect of the above stabilizer. Further, the above-mentioned pharmaceutical product may be produced by a step of heating at 37 ° C or higher.
另一方面,構成化粧品作為加工製品時,上述化粧品除上述成分以外,亦可包含本技藝者周知之成分。例如,本發明之一實施形態中,上述化粧品包含多酚、上述安定化劑及經核可作為化粧品使用之成分。作為上述成分,舉例有例如香料、金屬、陶瓷或賦形劑、崩解劑、結合劑、流動化劑、滑澤劑、著色劑、溶劑、油脂、界面活性劑、增黏劑、膠凝化劑等。化粧品之形態,並未 特別限制。基於與上述飲食品同樣之觀點,上述化粧品之pH亦可為4.0以上。由上述安定化劑之安定化效果之觀點而言,上述化粧品之pH較好在4.0~8.0,更好在4.0~7.5,又更好在5.5~6.5之範圍。且,上述化粧品亦可為經過於37℃以上加熱之步驟而製造者。 On the other hand, when the cosmetic is constituted as a processed product, the cosmetic may contain components well known to those skilled in the art in addition to the above components. For example, in one embodiment of the present invention, the cosmetic comprises a polyphenol, the stabilizer, and a component which can be used as a cosmetic via a core. As the above-mentioned components, for example, perfumes, metals, ceramics or excipients, disintegrators, binders, fluidizers, slip agents, colorants, solvents, greases, surfactants, tackifiers, gelatinization are exemplified. Agents, etc. The form of cosmetics, not Special restrictions. The pH of the above cosmetic may be 4.0 or more based on the same viewpoint as the above food and beverage. From the viewpoint of the stabilization effect of the above stabilizer, the pH of the above cosmetic is preferably from 4.0 to 8.0, more preferably from 4.0 to 7.5, still more preferably from 5.5 to 6.5. Further, the above-mentioned cosmetics may be manufactured by a step of heating at 37 ° C or higher.
<含有多酚之加工製品之製造方法> <Method for Producing Processed Article Containing Polyphenols>
本發明之第四樣態係有關含有多酚之加工製品之製造方法。上述製造方法包含下述步驟:(a)調製含有多酚與包含鞣花酸及安石榴苷之至少一者之安定化劑之組成物的步驟,(b)使用上述組成物,調製含有多酚之加工製品的步驟,(c)將前述含有多酚之加工製品加熱至37℃以上之溫度的步驟。上述製造方法中,上述加工製品宜與本發明之第三樣態相同。至於本發明之製造方法之一實施形態,上述步驟(a)中,較好相對於多酚100重量份,至少以鞣花酸成為1.5重量份以上或安石榴苷成為5重量份以上之比例與上述安定化劑共存。上述含有多酚之加工製品之pH宜為4.0~8.0之範圍。且,上述多酚較好為原花青素類及兒茶素類之至少一者。 The fourth aspect of the present invention relates to a method of producing a processed article containing polyphenol. The above production method comprises the steps of: (a) preparing a composition comprising a polyphenol and a stabilizer containing at least one of ellagic acid and punical guaranurine, and (b) using the above composition to prepare a polyphenol The step of processing the product, (c) the step of heating the processed product containing the polyphenol to a temperature of 37 ° C or higher. In the above production method, the above-mentioned processed product is preferably the same as the third aspect of the present invention. In one embodiment of the production method of the present invention, in the step (a), it is preferred that at least 1.5 parts by weight of ellagic acid or 5 parts by weight of guaranuric acid are added to 100 parts by weight of the polyphenol. The above stabilizers coexist. The pH of the above-mentioned polyphenol-containing processed product is preferably in the range of 4.0 to 8.0. Further, the polyphenol is preferably at least one of a proanthocyanidin and a catechin.
<多酚之安定化方法> <Method for the stabilization of polyphenols>
本發明之第五樣態係有關多酚之安定化方法,其特徵為相對於多酚100重量份,至少以鞣花酸為1.5重量份以上或安石榴苷為5重量份以上之比例共存。上述多酚、上 述鞣花酸、上述原花青素如先前所說明。如先前所說明,在pH4.0以上中會見到表兒茶素類之差向異構化或原花青素類減低之不期望現象。因此,由有效實施本發明安定化方法之觀點而言,上述安定化較好在pH4.0以上之條件下實施。上述安定化之pH條件,較好在4.0~8.0,又更好在4.0~7.5,最好在5.5~6.5之範圍。 The fifth aspect of the present invention relates to a method for the stabilization of polyphenols, which is characterized in that at least 1.5 parts by weight of ellagic acid or 5 parts by weight or more of guaranuric acid coexist with respect to 100 parts by weight of polyphenol. Above polyphenols, on The ellagic acid, the above proanthocyanidins are as previously described. As explained earlier, an undesirable phenomenon of epimerization or reduction of proanthocyanidins of epicatechins can be seen at pH 4.0 or higher. Therefore, from the viewpoint of effectively carrying out the stabilization method of the present invention, the above stabilization is preferably carried out under conditions of pH 4.0 or higher. The pH condition of the above stabilization is preferably from 4.0 to 8.0, more preferably from 4.0 to 7.5, and most preferably from 5.5 to 6.5.
上述pH條件下,進而藉由應用加熱,會促進上述多酚之構造變化。因此,基於更有效地實施本發明安定化之觀點,上述安定化除了上述pH條件以外,較好進而在37℃以上加熱之條件下,更好在120℃以上加熱之條件下,實施上述安定化。 Under the above-mentioned pH conditions, structural changes of the above polyphenols are promoted by application of heating. Therefore, in view of more effective implementation of the stabilization of the present invention, in addition to the above-mentioned pH conditions, it is preferred to carry out the above stabilization under the conditions of heating at 37 ° C or higher, preferably at 120 ° C or higher. .
本發明之另一樣態係有關含有多酚之加工製品,其係以本發明第三樣態之製造方法製造之由飲食品、醫藥品及化粧品所組成群組選擇者。且,進而其他樣態係有關鞣花酸及安石榴苷之至少一者作為多酚安定化劑之使用。 Another aspect of the present invention relates to a processed article containing polyphenols which is selected from the group consisting of foods, foods, pharmaceuticals, and cosmetics manufactured by the method of the third aspect of the present invention. Further, in other aspects, at least one of ellagic acid and punica glucoside is used as a polyphenol stabilizer.
以上,針對本發明基於代表性樣態加以說明。然而,本發明並不限定於所例示之樣態,當然在不脫離本發明主旨之範圍內亦可進行各種變更。 The above description is based on the representative aspect of the present invention. However, the present invention is not limited to the illustrated embodiments, and various modifications can be made without departing from the spirit and scope of the invention.
以下,列舉實施例具體說明本發明。然而,本發明之實施形態不限定無以下之實施例。 Hereinafter, the present invention will be specifically described by way of examples. However, the embodiments of the present invention are not limited to the following embodiments.
實施例及比較例中,各成分之定量分析係如 下般實施。 In the examples and comparative examples, the quantitative analysis of each component is as follows. Implemented as follows.
(鞣花酸、安石榴苷) (ellagic acid, pomegranate)
鞣花酸及安石榴苷之定量分析係參考非專利文獻1(J.Agric.Food Chem.,Vol.55 No.23,9559-9570,2007)所記載之方法實施。 The quantitative analysis of ellagic acid and punical glucoside is carried out by referring to the method described in Non-Patent Document 1 (J. Agric. Food Chem., Vol. 55 No. 23, 9559-9570, 2007).
(表體兒茶素類、非表體兒茶素類) (epidermal catechins, non-epi catechins)
表體兒茶素類(表兒茶素、表沒食子酸兒茶素、表兒茶素沒食子酸酯、表沒食子酸兒茶素沒食子酸酯)及非表體兒茶素類(兒茶素、沒食子酸兒茶素、兒茶素沒食子酸酯、沒食子酸兒茶素沒食子酸酯)之定量分析係參考非專利文獻2(Biosci.Biotechnol.Biochem.,Vol.64 No.12,2581-2587,2000)所記載之方法實施。 Epigenetic catechins (epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate) and non-epidermal Quantitative analysis of the tea catechins (catechin, gallic acid catechin, catechin gallate, gallic acid catechin gallate) is based on Non-Patent Document 2 (Biosci. The method described in Biotechnol. Biochem., Vol. 64 No. 12, 2581-2587, 2000) was carried out.
(原花青素類) (original anthocyanins)
原花青素類(兒茶素、表兒茶素、原花青素B2、原花青素B5、原花青素C1、桂皮鞣質A2)之定量分析係參考非專利文獻3(J.Agric.Food Chem.,Vol.45 No.12,4624-4628,1997)實施。 Quantitative analysis of proanthocyanidins (catechin, epicatechin, proanthocyanidin B2, proanthocyanidin B5, proanthocyanidin C1, cassia tannin A2) is based on Non-Patent Document 3 (J. Agric. Food Chem., Vol. 45 No. 12) , 4624-4628, 1997) Implementation.
實施例及比較例中使用之可可亞多酚係如下調製。 The cocopolyphenols used in the examples and comparative examples were prepared as follows.
(可可亞多酚之調製方法) (Modulation method of cocoa polyphenol)
將在產地已完成乾燥之可可亞豆磨碎,進而利用壓榨脫脂後,添加20倍量之50%乙醇水溶液,於50℃攪拌30分鐘。接著,利用離心去除不要成分,而獲得可可亞粗萃取液。 The cocoa beans which have been dried in the production area are ground and further degreased by pressing, and a 20-fold amount of 50% aqueous ethanol solution is added and stirred at 50 ° C for 30 minutes. Next, the undesired component is removed by centrifugation to obtain a crude extract of cocoa.
接著,於填充有預先施以氫離子交換處理之陽離子交換樹脂(Amberlite(註冊商標)IR-120B)之管柱中,以SV=5之流速通入上述可可亞粗萃取液。接著,於管柱中通入25℃之去離子水,分取溶出液。藉由使上述溶出液冷凍乾燥而獲得可可亞多酚(原花青素類含量約16重量%)。 Next, in the column packed with the cation exchange resin (Amberlite (registered trademark) IR-120B) to which hydrogen ion exchange treatment was previously applied, the above-mentioned crude extract of cocoa was introduced at a flow rate of SV=5. Next, deionized water at 25 ° C was passed through the column, and the eluate was separated. Cocoa polyphenol (proanthocyanidin content of about 16% by weight) was obtained by freeze-drying the above-mentioned eluate.
(實施例1) (Example 1)
各種植物萃取物之多酚安定化效果(殺菌前後) Polyphenol stabilization effect of various plant extracts (before and after sterilization)
(i)飲料之調製 (i) modulation of beverages
於依據上述方法所得之可可亞多酚625mg(原花青素含量100mg)與表1所示之植物萃取物(或試藥)350mg中,添加水而調製350ml溶液。使用0.1M鹽酸或0.1M氫氧化鈉將上述溶液調整至pH5.5,作成飲料。 To 350 mg of the plant extract (or reagent) shown in Table 1 and 625 mg of the cocoa polyphenol (100 mg of proanthocyanidin) obtained by the above method, water was added to prepare 350 ml of a solution. The above solution was adjusted to pH 5.5 using 0.1 M hydrochloric acid or 0.1 M sodium hydroxide to prepare a beverage.
(ii)殺菌 (ii) sterilization
將上述飲料封入密封容器中,以高壓釜在121℃加熱殺菌10分鐘。 The above beverage was sealed in a sealed container and heat-sterilized at 121 ° C for 10 minutes in an autoclave.
(iii)多酚分析 (iii) Polyphenol analysis
針對上述(i)所得之加熱殺菌前飲料及於上述(ii)所得之加熱殺菌後之各飲料,依據上述定量方法分別定量原花青素類。 The proanthocyanidins are respectively quantified according to the above-described quantitative methods for the pre-heat sterilization beverage obtained in the above (i) and the respective beverages after the heat sterilization obtained in the above (ii).
(iv)原花青素類減低抑制效果之評價 (iv) Evaluation of the reduction effect of proanthocyanidins
使用上述(iii)所得之原花青素類之各成分量,如下 述算出原花青素類殘存率。 The amount of each component of the proanthocyanidins obtained by the above (iii) is as follows The residual rate of proanthocyanidins is calculated.
原花青素類殘存率(%)=(加熱殺菌後之飲料中原花青素類成分之總和/加熱殺菌前之飲料中原花青素類成分之總和)*100 Residual rate of proanthocyanidins (%) = (sum of proanthocyanidins in beverages after heat sterilization / sum of proanthocyanidins in beverages before heat sterilization) *100
上述殘存率數值越高,表示加熱殺菌後之飲料中原花青素類越安定地保存。亦即,顯示原花青素類減低抑制效果越高。結果示於圖1。 The higher the residual ratio value, the more stable the proanthocyanidins in the beverage after heat sterilization. That is, it shows that the reduction effect of the proanthocyanidins is higher. The results are shown in Figure 1.
如圖1所見可知,紅石榴萃取物(1)、紅石榴萃取物(2)、洋甘子萃取物以及山竺萃取物在加熱殺菌後顯示高如80%以上之原花青素類殘存率。尤其,兩種紅石榴萃取物(含有鞣花酸40%~90%)顯示為具有較高之原花青素類減低抑制效果之多酚安定化劑。 As can be seen from Fig. 1, the red pomegranate extract (1), the red pomegranate extract (2), the orange gum extract and the hawthorn extract showed a residual rate of proanthocyanidins as high as 80% or more after heat sterilization. In particular, two red pomegranate extracts (containing 40% to 90% of ellagic acid) are shown as polyphenol stabilizers having a higher inhibitory effect on proanthocyanidins.
(v)差向異構化抑制效果之評價 (v) Evaluation of inhibitory effect of epimerization
差向異構物比率係使用上述(iii)中定量之原花青素類中之表兒茶素、兒茶素之數值,如下述算出。 The epimer ratio was calculated by using the values of epicatechin and catechin in the proanthocyanidins quantified in the above (iii).
差向異構物比率(%)=(各飲料中之表兒茶素類/各飲料中表兒茶素量+兒茶素量)*100 Epimer ratio (%) = (epicate catechins in each beverage / epicatechin amount in each beverage + catechin amount) * 100
加熱殺菌後之各飲料中差向異構物比率之數值越接近加熱殺菌前之飲料中差向異構物比率之數值,亦即為較高的數值,則表示加熱殺菌後之飲料中表兒茶素並未差向異構化成兒茶素,而以表兒茶素安定地保存。結果示於圖2。 The closer the value of the epimer ratio in each beverage after heat sterilization is the value of the ratio of the epimers in the beverage before sterilization, that is, the higher value indicates the surface of the beverage after heat sterilization. The tea is not heterogeneously converted into catechins, but is preserved with epicatechin. The results are shown in Figure 2.
如圖2所見可知,紅石榴萃取物(1)、紅石 榴萃取物(2)於加熱殺菌後顯示70%以上之高的差向異構物比率。亦即,兩種紅石榴萃取物(含有鞣花酸40%~90%)顯示為顯著較高之差向異構化抑制效果之多酚安定化劑。 As seen in Figure 2, red pomegranate extract (1), redstone The extract of the extract (2) shows a ratio of epimers higher than 70% after heat sterilization. That is, the two red pomegranate extracts (containing 40% to 90% of ellagic acid) show a polyphenol stabilizer which is a significantly higher epimerization inhibitory effect.
(實施例2) (Example 2)
各種植物萃取物之多酚安定化效果(加溫保存) Polyphenol stabilization effect of various plant extracts (heat preservation)
使實施例1中調製之殺菌後之飲料在37℃保存2週。針對保存後之各飲料,依據與實施例1(iii)~(v)同樣方法算出原花青素類殘存率及差向異構物比率。未添加、紅石榴萃取物(1)、紅石榴萃取物(2)、洋甘子萃取物之結果示於圖3及圖4。 The sterilized beverage prepared in Example 1 was stored at 37 ° C for 2 weeks. The procyanidins residual ratio and the epimer ratio were calculated for each of the drinks after storage in the same manner as in Examples 1 (iii) to (v). The results of the unadded, red pomegranate extract (1), red pomegranate extract (2), and orange gum extract are shown in Fig. 3 and Fig. 4.
如由圖3及圖4所見可知,添加有洋甘子萃取物及紅石榴萃取物之飲料,經過加熱殺菌在37℃保存2週後,具有比未添加植物萃取物之飲料更高之原花青素類殘存率及差向異構物比率。尤其,兩種紅石榴萃取物(含有鞣花酸40%~90%)顯示為在加溫保存條件下原花青素類減低抑制效果及差向異構化抑制效果亦高之多酚安定化劑。 As can be seen from FIG. 3 and FIG. 4, the beverage to which the orange extract and the pomegranate extract were added was subjected to heat sterilization and stored at 37 ° C for 2 weeks, and the proanthocyanidins remained higher than the beverage without the added plant extract. Rate and epimer ratio. In particular, the two red pomegranate extracts (containing 40% to 90% of ellagic acid) are polyphenol stabilizers which have a low inhibitory effect on proanthocyanidins and a high inhibitory effect on epimerization under warm storage conditions.
(實施例3) (Example 3)
紅石榴萃取物(鞣花酸含量90%)之多酚安定化效果 Polyphenol stability of red pomegranate extract (90% ellagic acid)
(i)飲料之調製 (i) modulation of beverages
使用實施例1之紅石榴萃取物(1)(日本BIO ACTIVES製,鞣花酸含量90%),依據與實施例1(i)~(iii)同樣之方法調製飲料。但,關於上述萃取物之調配量,飲料350ml中分別設為0mg、1.75mg(5ppm)、3.5mg(10ppm)、8.75mg(25ppm)、17.5mg(50ppm)、35mg(100ppm)、87.5mg(250ppm)、175mg(500ppm)、350mg(1000ppm)。 Using the red pomegranate extract (1) of Example 1 (manufactured by BIO ACTIVES, Japan, 90% ellagic acid content), the beverage was prepared in the same manner as in Examples 1 (i) to (iii). However, regarding the blending amount of the above extract, 350 mg of the beverage was set to 0 mg, 1.75 mg (5 ppm), 3.5 mg (10 ppm), 8.75 mg (25 ppm), 17.5 mg (50 ppm), 35 mg (100 ppm), and 87.5 mg, respectively. 250 ppm), 175 mg (500 ppm), 350 mg (1000 ppm).
使上述(i)調製之飲料與實施例1(ii)同樣進行加熱殺菌。針對加熱殺菌前後之飲料,依據與實施例1(iii)~(v)同樣之方法,分析多酚,算出原花青素類殘存率及差向異構物比率。結果示於圖5及圖6。 The beverage prepared in the above (i) was heat-sterilized in the same manner as in Example 1 (ii). The polyphenols were analyzed in the same manner as in Examples 1 (iii) to (v) for the beverages before and after the heat sterilization, and the residual ratio of the proanthocyanidins and the ratio of the epimers were calculated. The results are shown in Figures 5 and 6.
如圖5及圖6所見可知,藉由於飲料中添加5~1000ppm之上述紅石榴萃取物,濃度依存地增加了原花青素類殘存率及差向異構物比率。 As can be seen from Fig. 5 and Fig. 6, by adding 5 to 1000 ppm of the above-mentioned red pomegranate extract to the beverage, the concentration of the proanthocyanidins and the ratio of epimers were increased depending on the concentration.
亦即,藉由於含有原花青素類100mg之飲料中調配含有90%鞣花酸之紅石榴萃取物5ppm以上(以鞣花酸計為1.575mg以上),顯示可抑制原花青素類之減低以及抑制表體兒茶素類之差向異構化。 In other words, by adding 5 ppm or more of the red pomegranate extract containing 90% ellagic acid to the beverage containing 100 mg of proanthocyanidins (1.575 mg or more in terms of ellagic acid), it is shown that the reduction of proanthocyanidins and the inhibition of the epidermis are suppressed. The isomerization of the tea compounds.
再者,將本實施例所調製之殺菌後飲料在37℃保存2週。針對保存後之飲料,依據與實施例1(iii)~(v)同樣之方法,分析各飲料之多酚,算出原花青素類殘存率及差向異構物比率。結果示於圖7及圖8。 Further, the sterilized beverage prepared in the present example was stored at 37 ° C for 2 weeks. With respect to the preserved beverage, the polyphenols of each beverage were analyzed in the same manner as in Examples 1 (iii) to (v), and the residual ratio of proanthocyanidins and the ratio of epimers were calculated. The results are shown in Figures 7 and 8.
如圖7及圖8所見可知,添加含有90%鞣花酸之紅石榴萃取物之飲料,經過加熱殺菌後於37℃保存2 週後,具有比未添加安定化劑之飲料更高之原花青素類殘存率及差向異構物比率。 As can be seen from Fig. 7 and Fig. 8, the beverage containing the red pomegranate extract containing 90% ellagic acid was heat-sterilized and stored at 37 ° C. After the week, there were higher procyanidins residual ratios and epimerization ratios than the beverages to which no stabilizer was added.
(實施例4) (Example 4)
各種紅石榴萃取物(鞣花酸含量15~40%,安石榴苷含量30%)之多酚安定化效果 Polyphenol stability of various red pomegranate extracts (15-40% ellagic acid content, 30% pomegranate content)
(i)飲料之調製 (i) modulation of beverages
使用實施例1之紅石榴萃取物(2)(NATURAX製,鞣花酸含量40%)、紅石榴萃取物(3)(ARJUNA製,水解後之鞣花酸含量15%)、紅石榴萃取物(4)(OMNICA製,安石榴苷含量30%),依據實施例1(i)~(ii)記載之方法,調製飲料。但,關於上述萃取物之調配量,紅石榴萃取物(2)於飲料中為250~1000ppm,紅石榴萃取物(3)及紅石榴萃取物(4)為50~500ppm。 Using the pomegranate extract (2) of Example 1 (manufactured by NATURAX, ellagic acid content 40%), pomegranate extract (3) (manufactured by ARJUNA, 15% ellagic acid after hydrolysis), red pomegranate extract (4) (manufactured by OMNICA, 30% guaranin content), the beverage was prepared according to the method described in Examples 1 (i) to (ii). However, regarding the blending amount of the above extract, the red pomegranate extract (2) is 250 to 1000 ppm in the beverage, and the red pomegranate extract (3) and the red pomegranate extract (4) are 50 to 500 ppm.
使上述(i)所調製之飲料與實施例1(ii)同樣進行加熱殺菌。針對加熱殺菌前後之飲料,依據與實施例1(iii)~(v)同樣之方法,分析多酚,算出原花青素類殘存率及差向異構物比率。結果示於圖9及圖10。 The beverage prepared in the above (i) was heat-sterilized in the same manner as in Example 1 (ii). The polyphenols were analyzed in the same manner as in Examples 1 (iii) to (v) for the beverages before and after the heat sterilization, and the residual ratio of the proanthocyanidins and the ratio of the epimers were calculated. The results are shown in Figures 9 and 10.
再者,使本實施例調製之殺菌後飲料在37℃保存2週。關於紅石榴萃取物(3)及紅石榴萃取物(4),則在37℃保存2個月。針對保存後之飲料,依據與實施例1(iii)~(v)同樣之方法,分析各飲料之多酚,算出原花青素類殘存率及差向異構物比率。紅石榴萃 取物(2)之結果示於圖11及圖12。且,紅石榴萃取物(3)之結果示於圖13及圖14。紅石榴萃取物(4)之結果示於圖15及圖16。 Further, the sterilized beverage prepared in the present example was stored at 37 ° C for 2 weeks. About red pomegranate extract (3) and red pomegranate extract (4), they were stored at 37 ° C for 2 months. With respect to the preserved beverage, the polyphenols of each beverage were analyzed in the same manner as in Examples 1 (iii) to (v), and the residual ratio of proanthocyanidins and the ratio of epimers were calculated. Red pomegranate extract The results of the extract (2) are shown in Fig. 11 and Fig. 12. Further, the results of the red pomegranate extract (3) are shown in Fig. 13 and Fig. 14. The results of the red pomegranate extract (4) are shown in Figs. 15 and 16.
如圖9及圖10所見可知,藉由於飲料中添加50~1000ppm之上述紅石榴萃取物(2)~(4),濃度依存地增加了原花青素類殘存率及差向異構物比率。且,如由圖11~圖16所見可知,添加有含15~40%鞣花酸或含30%安石榴苷之紅石榴萃取物之飲料,經過加熱殺菌並在37℃保存後,具有比未添加安定化劑之飲料更高之原花青素類殘存率及差向異構物比率。 As can be seen from Fig. 9 and Fig. 10, by adding 50 to 1000 ppm of the above-mentioned red pomegranate extracts (2) to (4) to the beverage, the concentration of the proanthocyanidins and the ratio of epimers are increased depending on the concentration. Moreover, as can be seen from Fig. 11 to Fig. 16, a beverage containing 15 to 40% ellagic acid or a pomegranate extract containing 30% punical glucoside is heat-sterilized and stored at 37 ° C. The higher the original anthocyanin residual rate and the epimerization ratio of the beverage added with the stabilizer.
亦即,藉由於含有原花青素類100mg之飲料中調配含有30%安石榴苷之紅石榴萃取物50ppm以上(以安石榴苷計為5.25mg以上),顯示可抑制原花青素類之減低以及抑制表體兒茶素類之差向異構化。 That is, by adding 50 ppm or more of the pomegranate extract containing 30% punical guaiacin in a beverage containing 100 mg of proanthocyanidins (5.25 mg or more in terms of pomegranate), it is shown to inhibit the reduction of proanthocyanidins and inhibit the appearance of the body. The isomerization of the tea compounds.
(實施例5) (Example 5)
鞣花酸純化品、安石榴苷純化品之多酚安定化效果 Polyphenol stability of ellagic acid purified product and purified pomegranate
(i)飲料之調製 (i) modulation of beverages
使用鞣花酸(和光純藥工業製,鞣花酸二水合物99.0%以上)及安石榴苷(SIGMA公司製),依據與實施例1(i)~(ii)同樣之方法,調製飲料。但,關於上述萃取物之調配量,鞣花酸於飲料350ml中為0~350mg(1000ppm),安石榴苷為35mg(100ppm)。 The beverage was prepared in the same manner as in Example 1 (i) to (ii) using ellagic acid (manufactured by Wako Pure Chemical Industries, Ltd., yttrium acid dihydrate 99.0% or more) and guavaside (manufactured by SIGMA Co., Ltd.). However, regarding the blending amount of the above extract, ellagic acid is 0 to 350 mg (1000 ppm) in 350 ml of the beverage, and garnetin is 35 mg (100 ppm).
使上述(i)調製之飲料與實施例1(ii)同樣進行加熱殺菌。針對加熱殺菌前後之飲料,依據與實施例1(iii)~(v)同樣之方法,分析多酚,算出原花青素類殘存率及差向異構物比率。結果示於圖17及圖18。 The beverage prepared in the above (i) was heat-sterilized in the same manner as in Example 1 (ii). The polyphenols were analyzed in the same manner as in Examples 1 (iii) to (v) for the beverages before and after the heat sterilization, and the residual ratio of the proanthocyanidins and the ratio of the epimers were calculated. The results are shown in Fig. 17 and Fig. 18.
如圖17及圖18所見可知,藉由於飲料中添加5~1000ppm之鞣花酸,濃度依存地增加了原花青素類殘存率及差向異構物比率。亦即,藉由在含有100mg原花青素類之飲料中調配5ppm(1.75mg)以上或100ppm(35mg)以上安石榴苷,顯示可抑制飲料中原花青素類之減低以及抑制飲料中之表體兒茶素類之差向異構化。 As can be seen from Fig. 17 and Fig. 18, by adding 5 to 1000 ppm of ellagic acid to the beverage, the concentration of the proanthocyanidins and the ratio of epimers were increased depending on the concentration. That is, by formulating 5 ppm (1.75 mg) or more or 100 ppm (35 mg) or more of punical punical glucoside in a beverage containing 100 mg of proanthocyanidins, it is shown that the reduction of proanthocyanidins in the beverage can be suppressed and the epicatechin catechins in the beverage can be inhibited. The difference is isomerized.
再者,使本實施例調製之殺菌後飲料在37℃保存2個月。針對保存後之飲料,依據與實施例1(iii)~(v)同樣之方法,分析各飲料之多酚,算出原花青素類殘存率及差向異構物比率。調配鞣花酸之飲料之結果示於圖19及圖20。 Further, the sterilized beverage prepared in the present example was stored at 37 ° C for 2 months. With respect to the preserved beverage, the polyphenols of each beverage were analyzed in the same manner as in Examples 1 (iii) to (v), and the residual ratio of proanthocyanidins and the ratio of epimers were calculated. The results of the blending of the ellagic acid beverage are shown in Figs. 19 and 20.
如由圖19~圖20所見可知,添加有5~1000ppm鞣花酸之飲料,經過加熱殺菌並在37℃保存2個月後,具有比未添加安定化劑之飲料更高之原花青素類殘存率及差向異構物比率。 As can be seen from Fig. 19 to Fig. 20, the beverage added with 5 to 1000 ppm of ellagic acid, after heat sterilization and storage at 37 ° C for 2 months, has a higher residual rate of proanthocyanidins than the beverage without the stabilizer. And epimer isomer ratio.
再者,使上述試驗飲料在37℃保存3個月後,測定試驗飲料(調配鞣花酸100ppm)中之鞣花酸含量後,相對於調配量之理論值,為101%之殘存率。 Further, after the test beverage was stored at 37 ° C for 3 months, the ellagic acid content in the test beverage (100 ppm of ellagic acid) was measured, and the residual value was 101% with respect to the theoretical value of the blended amount.
(實施例6) (Example 6)
鞣花酸純化品之多酚(兒茶素類)安定化效果 Stabilizing effect of polyphenols (catechins) from ellagic acid purified products
(i)飲料之調製 (i) modulation of beverages
對於茶多酚(和光純藥工業製,製品名:兒茶素混合物,源自綠茶)625mg與鞣花酸(和光純藥工業製,鞣花酸二水合物99.0%以上)0mg、35mg(100ppm)添加水,調製350ml溶液。使用0.1M鹽酸或0.1M氫氧化鈉將上述溶液調整至pH6.5作成飲料。 For tea polyphenol (manufactured by Wako Pure Chemical Industries, product name: catechin mixture, derived from green tea) 625 mg and ellagic acid (manufactured by Wako Pure Chemical Industries, yroic acid dihydrate 99.0% or more) 0 mg, 35 mg (100 ppm) Water was added to prepare a 350 ml solution. The above solution was adjusted to pH 6.5 using 0.1 M hydrochloric acid or 0.1 M sodium hydroxide to prepare a beverage.
(ii)殺菌 (ii) sterilization
將上述飲料封入密閉容器中之後,以高壓釜在121℃加熱殺菌10分鐘。 After the above beverage was sealed in a closed container, it was heat-sterilized at 121 ° C for 10 minutes in an autoclave.
(iii)多酚分析 (iii) Polyphenol analysis
針對上述(i)所得之加熱殺菌前之飲料以及上述(ii)所得之加熱殺菌後之各飲料,依據上述定量方法分別定量表體兒茶素類及非表體兒茶素類計8種成分。又,8種成分之簡稱如下。 The beverages before the heat sterilization obtained in the above (i) and the heat-sterilized beverages obtained in the above (ii) are respectively quantified according to the above quantitative methods: 8 components of the catechin catechins and the non-epi catechins. . Further, the abbreviation of the eight components is as follows.
表兒茶素:EC Epicatechin: EC
兒茶素:C Catechin: C
表沒食子兒茶素:EGC Epigallocatechin: EGC
沒食子兒茶素:GC Gallocatechin: GC
表兒茶素沒食子酸酯:ECG Epicatechin Gallate: ECG
兒茶素沒食子酸酯:CG Catechin gallate: CG
表沒食子兒茶素沒食子酸酯:EGCG Epigallocatechin gallate: EGCG
沒食子兒茶素沒食子酸酯:GCG Gallocatechin gallate: GCG
(iv)差向異構化抑制效果之評價 (iv) Evaluation of the inhibitory effect of epimerization
差向異構物比率係使用上述(iii)中定量之8種成分之數值,如下算出。 The epimer ratio was calculated by using the numerical values of the eight components quantified in the above (iii).
(a)差向異構物比率(%)=(各飲料中之EC含量/各飲料中之EC含量+C含量)*100 (a) Epimer ratio (%) = (EC content in each beverage / EC content in each beverage + C content) * 100
(b)差向異構物比率(%)=(各飲料中之EGC含量/各飲料中之EGC含量+GC含量)*100 (b) Epimer ratio (%) = (EGC content in each beverage / EGC content in each beverage + GC content) * 100
(c)差向異構物比率(%)=(各飲料中之ECG含量/各飲料中之ECG含量+CG含量)*100 (c) Epimer ratio (%) = (ECG content in each beverage / ECG content in each beverage + CG content) * 100
(d)差向異構物比率(%)=(各飲料中之EGCG含量/各飲料中之EGCG含量+GCG含量)*100 (d) Epimer ratio (%) = (EGCG content in each beverage / EGCG content in each beverage + GCG content) * 100
(e)差向異構物比率(%)=(各飲料中之表體兒茶素類含量總和/各飲料中之表體兒茶素類與非表體兒茶素類之總合)*100 (e) Epimer ratio (%) = (the sum of the surface catechins in each beverage / the total of the catechin catechins and non-epi catechins in each beverage) * 100
加熱殺菌後之各飲料之差向異構物比率數值越接近加熱殺菌前之飲料中差向異構物比率之數值,亦即為較高的數值,則表示加熱殺菌後之飲料中表體兒茶素類並未差向異構化成非表體兒茶素,而以表兒茶素類安定地保存。結果示於圖21。 The closer the value of the epimer ratio of each beverage after heat sterilization is to the value of the epimer ratio in the beverage before sterilization, that is, the higher value indicates the surface of the beverage after heat sterilization. The tea catechus are not heterogeneously converted into non-epi catechins, but are preserved stably with epicatechins. The results are shown in Fig. 21.
如圖21所見,未添加安定化劑之飲料中,由於因加熱殺菌使茶兒茶素類之表體兒茶素類差向異構化為 非表體兒茶素類,故任一成分之差向異構物比率均比殺菌後降低。另一方面,藉由於飲料中添加100ppm之鞣花酸,殺菌後之茶多酚之差向異構物比率顯示比未添加之飲料高的值。亦即,可知鞣花酸可使用作為抑制茶飲料中表體兒茶素類之差向異構化之多酚安定化劑。 As seen in Fig. 21, in the beverage without the stabilizer, the epicatechin catechins of the tea catechins were differentially isomerized due to heat sterilization. Non-epidermal catechins, so the ratio of epimers to any component is lower than after sterilization. On the other hand, by adding 100 ppm of ellagic acid to the beverage, the ratio of the difference to the isomer of the tea polyphenol after sterilization showed a higher value than the unadded beverage. That is, it is known that ellagic acid can be used as a polyphenol stabilizer for suppressing epimerization of epicatechins in tea beverages.
(實施例7) (Example 7)
各種濃度之鞣花酸之多酚(兒茶素類)安定化效果 Stabilization effect of polyphenols (catechins) of various concentrations of ellagic acid
(i)飲料之調製 (i) modulation of beverages
對於鞣花酸(和光純藥工業製,鞣花酸二水合物99.0%以上)0mg、3.5mg(10ppm)、8.75mg(25ppm)、17.5mg(50ppm)、35mg(100ppm)分別添加茶多酚(和光純藥工業製,製品名:兒茶素混合物,源自綠茶)625mg及水,調製350ml溶液。使用0.1M鹽酸或0.1M氫氧化鈉將上述溶液調整至pH6.5作成飲料。 For ellagic acid (manufactured by Wako Pure Chemical Industries, 99.0% or more of ellagic acid dihydrate), tea polyphenols were added at 0 mg, 3.5 mg (10 ppm), 8.75 mg (25 ppm), 17.5 mg (50 ppm), and 35 mg (100 ppm), respectively. (Wako Pure Chemical Industries, product name: catechin mixture, derived from green tea) 625mg and water, prepared 350ml solution. The above solution was adjusted to pH 6.5 using 0.1 M hydrochloric acid or 0.1 M sodium hydroxide to prepare a beverage.
(ii)殺菌 (ii) sterilization
將上述飲料封入密閉容器中之後,以高壓釜在121℃加熱殺菌10分鐘。 After the above beverage was sealed in a closed container, it was heat-sterilized at 121 ° C for 10 minutes in an autoclave.
與實施例6同樣地,定量各試驗區之表體兒茶素類及非表體兒茶素類,算出差向異構物比率。(e)差向異構物比率(全部表體兒茶素類)之結果示於圖22。 In the same manner as in Example 6, the epicatechin catechins and non-epi catechins in each test zone were quantified, and the epimer ratio was calculated. The results of (e) epimer ratio (all epicatechin catechins) are shown in Fig. 22 .
如圖22所見可知,藉由於飲料中添加10~100ppm之鞣花酸,殺菌後之茶多酚之差向異構物比率濃度依存地顯示較高值。雖未於圖22中顯示,但各表體兒茶素類成分之差向異構物比率(a)~(d)均同樣與鞣花酸濃度依存地顯示較高值。 As can be seen from Fig. 22, by adding 10 to 100 ppm of ellagic acid to the beverage, the ratio of the difference to the isomer ratio of the tea polyphenol after sterilization showed a high value. Although not shown in Fig. 22, the ratio of the epimers (a) to (d) of the catechin components of the respective forms showed a high value depending on the concentration of ellagic acid.
再者,使本實施例調製之殺菌後飲料在37℃保存2個月。針對保存後之飲料,依據與實施例6(iii)~(v)同樣之方法,分析各飲料之多酚,定量各試驗區之表體兒茶素類及非表體兒茶素類,算出差向異構物比率。(e)差向異構物比率(全部表體兒茶素類)之結果示於圖23。 Further, the sterilized beverage prepared in the present example was stored at 37 ° C for 2 months. For the preserved beverage, the polyphenols of each beverage were analyzed in the same manner as in Examples 6 (iii) to (v), and the catechin catechins and non-epi catechins in each test zone were quantified. Epimer ratio. The results of (e) epimer ratio (all epicatechin catechins) are shown in Fig. 23.
如由圖23所見可知,添加有10~100ppm鞣花酸之飲料,經過加熱殺菌並在37℃保存2個月後,具有比未添加安定化劑之飲料更高之差向異構物比率。雖未於圖23中顯示,但各表體兒茶素類成分之差向異構物比率(a)~(d)均同樣與鞣花酸濃度依存地顯示較高值。 As can be seen from Fig. 23, the beverage to which 10 to 100 ppm of ellagic acid was added was subjected to heat sterilization and stored at 37 ° C for 2 months, and had a higher ratio of epimers than a beverage to which no stabilizer was added. Although not shown in Fig. 23, the epimer ratios (a) to (d) of the respective catechin components showed a high value depending on the concentration of ellagic acid.
(實施例8) (Example 8)
含可可亞多酚之飲料(pH5.5)中之多酚安定化效果 Polyphenol stabilization effect in cocoa polyphenol-containing beverage (pH 5.5)
(i)飲料之調製 (i) modulation of beverages
於依據上述方法所得之可可亞多酚625mg(原花青素類含量100mg)與鞣花酸(試藥)或紅石榴萃取物(4)(含安石榴苷30%)35mg(100ppm)中添加水,調製 350ml溶液。使用0.1M鹽酸或0.1M氫氧化鈉將上述溶液調整至pH6.5作成飲料。 Adding water to 625 mg (proanthocyanidin content 100 mg) of cocoa polyphenol obtained according to the above method, and lyric acid (test drug) or red pomegranate extract (4) (containing punny pomegranate 30%) 35 mg (100 ppm) 350 ml solution. The above solution was adjusted to pH 6.5 using 0.1 M hydrochloric acid or 0.1 M sodium hydroxide to prepare a beverage.
將上述(i)調製之飲料以與實施例1(ii)同樣進行加熱殺菌。針對加熱殺菌前後及在37℃保存兩週之飲料,依據與實施例1(iii)~(v)同樣之方法分析多酚,算出原花青素類殘存率及差向異構物比率。結果示於圖24及25。 The beverage prepared in the above (i) was heat-sterilized in the same manner as in Example 1 (ii). The polyphenols were analyzed in the same manner as in Examples 1 (iii) to (v) before and after heat sterilization and at a temperature of 37 ° C for two weeks, and the residual ratio of anthocyanins and the ratio of epimers were calculated. The results are shown in Figures 24 and 25.
如圖24及圖25所見可知,即使對於pH6.5之含有可可亞多酚之飲料,藉由於飲料中添加100ppm之含有鞣花酸獲安石榴苷之安定化劑,原花青素類殘存率及差向異構物比率亦增加。 As can be seen from Fig. 24 and Fig. 25, even for the beverage containing cocoa polyphenol at pH 6.5, the residual rate and the difference of the proanthocyanidins were obtained by adding 100 ppm of the stabilizer containing ellagic acid to the beverage. The isomer ratio also increased.
(比較例1) (Comparative Example 1)
沒食子酸對多酚安定化之影響 Effect of gallic acid on polyphenol stability
(i)飲料之調製 (i) modulation of beverages
於依據上述方法所得之可可亞多酚625mg(原花青素類含量100mg)與鞣花酸(試藥)或沒食子酸(試藥)各35mg(100ppm)中添加水,調製350ml溶液。使用0.1M鹽酸或0.1M氫氧化鈉將上述溶液調整至pH5.5作成飲料。 To a solution of 625 mg (proanthocyanidin content: 100 mg) of cocoa polyphenol obtained by the above method, and 35 mg (100 ppm) of each of ellagic acid (test drug) or gallic acid (test drug), water was added to prepare a 350 ml solution. The above solution was adjusted to pH 5.5 using 0.1 M hydrochloric acid or 0.1 M sodium hydroxide to prepare a beverage.
將上述(i)調製之飲料以與實施例1(ii)同樣進行加熱殺菌。針對加熱殺菌前後之各飲料,依據與實施例1(iii)~(v)同樣之方法分析多酚,算出原花青素類殘存率及差向異構物比率。結果示於圖26及27。 The beverage prepared in the above (i) was heat-sterilized in the same manner as in Example 1 (ii). The polyphenols were analyzed in the same manner as in Examples 1 (iii) to (v) for each of the beverages before and after the heat sterilization, and the residual ratio of the proanthocyanidins and the ratio of the epimers were calculated. The results are shown in Figures 26 and 27.
如圖26及圖27所了解,沒食子酸並未確認到多酚之安定化效果。 As understood from Fig. 26 and Fig. 27, gallic acid did not confirm the stabilization effect of polyphenols.
(參考例1) (Reference example 1)
各種植物萃取物之抗氧化活性與總多酚量 Antioxidant activity and total polyphenol content of various plant extracts
針對實施例1使用之植物萃取物(生薑萃取物、抗壞血酸、紅石榴萃取物(2)除外),測定抗氧化活性(DPPH自由基消除能力)及總多酚量。 For the plant extract (except ginger extract, ascorbic acid, and pomegranate extract (2)) used in Example 1, antioxidant activity (DPPH radical scavenging ability) and total polyphenol amount were measured.
(DPPH自由基消除能力) (DPPH free radical elimination ability)
DPPH(1,1-二苯基-2-苷位基聯肼基,1,1-Dyphenyl-2-picrylhydarzyl)自由基消除能力係依據非專利文獻4所記載之方法測定。測定方法概略如下。 The DPPH (1,1-diphenyl-2-glycosylfluorenyl group, 1,1-Dyphenyl-2-picrylhydarzyl) radical scavenging ability was measured according to the method described in Non-Patent Document 4. The measurement method is summarized as follows.
將各植物萃取物以80重量%甲醇水溶液溶解,調製自濃度1000ppm階段性稀釋之溶液。對上述溶液100μl添加0.1mM DPPH溶液2ml,於室溫靜置30分鐘後,測定520nm之吸光度。將DPPH溶液作為空白組,將其吸光度之值設為阻礙率100%,算出各試料溶液之阻礙率。以內插法求得上述阻礙率為50%之試料濃度(IC50)。IC50值越低,顯示DPPH自由基消除能力(抗氧化活性)越高。所得抗氧化活性之結果與由實施例1獲得之原花青素類殘存率之關係示於圖28。 Each of the plant extracts was dissolved in an 80% by weight aqueous methanol solution, and a solution having a stepwise dilution of 1000 ppm was prepared. To 100 μl of the above solution, 2 ml of a 0.1 mM DPPH solution was added, and after standing at room temperature for 30 minutes, the absorbance at 520 nm was measured. The DPPH solution was used as a blank group, and the absorbance value was set to 100% of the inhibition rate, and the inhibition ratio of each sample solution was calculated. The sample concentration (IC50) at which the above inhibition rate was 50% was determined by interpolation. The lower the IC50 value, the higher the DPPH radical scavenging ability (antioxidant activity). The relationship between the obtained antioxidant activity and the residual ratio of the proanthocyanidins obtained in Example 1 is shown in Fig. 28.
如圖28所了解,實施例1所用之各植物萃取物之抗氧化活性與原花青素類殘存率之間並未見到有意義 之相關性。 As understood from Fig. 28, there was no significant difference between the antioxidant activity of each plant extract used in Example 1 and the residual rate of proanthocyanidins. Relevance.
(總多酚量) (total amount of polyphenols)
總多酚量係藉由參考非專利文獻5中記載之方法,以市售沒食子酸作為標準品,進行各試料之定量分析所得之值。測定方法概略如下。 The total amount of polyphenols is obtained by quantitative analysis of each sample by referring to the method described in Non-Patent Document 5, using commercially available gallic acid as a standard. The measurement method is summarized as follows.
使用80重量%甲醇水溶液萃取各植物萃取物,作成試驗溶液。接著,於蒸餾水50ml中添加各試驗溶液100μl,邊攪拌邊添加0.1M硫酸鐵(III)銨-0.1M鹽酸溶液3ml,於其20分鐘後,添加8mM六胺基鐵(III)鉀水溶液3ml,再20分鐘後,測定720nm之吸光度。進而,使用於蒸餾水50ml中添加各樣品液之溶劑(80重量%甲醇)100μl者及沒食子酸(SIGMA公司製)80重量%甲醇溶液,進行同樣處理作成校正曲線,算出各試驗溶液中之總多酚量。所得總多酚量之結果與實施例1所得之原花青素類殘存率之相關性示於圖29。 Each of the plant extracts was extracted with an 80% by weight aqueous methanol solution to prepare a test solution. Next, 100 μl of each test solution was added to 50 ml of distilled water, and 3 ml of a 0.1 M ammonium iron (III) sulfate-0.1 M hydrochloric acid solution was added thereto with stirring, and after 20 minutes, 3 ml of an aqueous 8 mM hexaamine iron (III) solution was added thereto. After another 20 minutes, the absorbance at 720 nm was measured. Furthermore, 100 μl of a solvent (80% by weight of methanol) of each sample solution and 80% by weight of a methanol solution of gallic acid (manufactured by SIGMA Co., Ltd.) were added to 50 ml of distilled water, and a calibration curve was prepared in the same manner to calculate a test curve. The total amount of polyphenols. The correlation between the results of the total amount of polyphenol obtained and the residual ratio of proanthocyanidins obtained in Example 1 is shown in Fig. 29.
由圖29所了解,實施例1所用之各植物萃取物之總多酚量與原花青素類殘存率之間並未見到有意義之相關性。 As is understood from Fig. 29, no significant correlation was found between the total polyphenol amount of each plant extract used in Example 1 and the residual rate of proanthocyanidins.
推測本發明所發現之鞣花酸及安石榴苷所產生之多酚安定化效果,並非因抗氧化活性及總多酚量所引起者。 It is presumed that the polyphenol stabilizing effect produced by the ellagic acid and punica glucoside found in the present invention is not caused by the antioxidant activity and the total amount of polyphenols.
Claims (16)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012063364 | 2012-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201347687A true TW201347687A (en) | 2013-12-01 |
Family
ID=49222724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW102110041A TW201347687A (en) | 2012-03-21 | 2013-03-21 | Polyphenol stabilizer, and composition and processed goods containing said stabilizer |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP6371702B2 (en) |
TW (1) | TW201347687A (en) |
WO (1) | WO2013141267A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160011536A (en) * | 2014-07-22 | 2016-02-01 | (주) 건강사랑 | Composition for improving skin condition comprising pomegranate concentrate as active ingredient |
EP3233188A4 (en) * | 2014-12-19 | 2018-11-07 | Halo Life Science, LLC | Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels |
EP3790569A4 (en) * | 2018-05-08 | 2022-02-16 | Laila Nutraceuticals | Synergistic herbal compositions for testosterone boosting |
WO2023008455A1 (en) * | 2021-07-27 | 2023-02-02 | サントリーホールディングス株式会社 | Agent for suppressing epimerization of non-polymerized catechin, container-filling beverage containing epimeric non-polymerized catechin, and method for producing same |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030087566A (en) * | 2002-05-07 | 2003-11-14 | 액세스 비지니스 그룹 인터내셔날 엘엘씨 | Phytonutrient Nutritional Supplement |
JP2004222683A (en) * | 2003-01-27 | 2004-08-12 | Bio Oriented Technol Res Advancement Inst | Method for production for reinforcing antiallergic effect and functional beverage or food produced by the method |
JP2005245351A (en) * | 2004-03-05 | 2005-09-15 | Yakult Honsha Co Ltd | Acidic beverage |
JP2005350375A (en) * | 2004-06-09 | 2005-12-22 | Kikkoman Corp | Reducing agent for blood uric acid value |
JP2006273762A (en) * | 2005-03-30 | 2006-10-12 | Kikkoman Corp | Uricosuric agent |
JP5101193B2 (en) * | 2007-07-06 | 2012-12-19 | 富士フイルム株式会社 | Cosmetic composition |
US8945655B2 (en) * | 2007-07-10 | 2015-02-03 | Conopco, Inc. | Stable and consumable compositions |
EP2033526A1 (en) * | 2007-09-07 | 2009-03-11 | Probelte Pharma, S.A. | Nutritional products comprising pomegranate extracts containing ellagitannins and their use |
-
2013
- 2013-03-21 JP JP2014506259A patent/JP6371702B2/en not_active Expired - Fee Related
- 2013-03-21 TW TW102110041A patent/TW201347687A/en unknown
- 2013-03-21 WO PCT/JP2013/057953 patent/WO2013141267A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP6371702B2 (en) | 2018-08-08 |
JPWO2013141267A1 (en) | 2015-08-03 |
WO2013141267A1 (en) | 2013-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Almajano et al. | Antioxidant and antimicrobial activities of tea infusions | |
JP6463312B2 (en) | Bottled beverage containing quercetin glycoside | |
EP2172537A1 (en) | Degradation inhibitor for flavor or aroma | |
TW201347687A (en) | Polyphenol stabilizer, and composition and processed goods containing said stabilizer | |
TWI735617B (en) | Instant powder tea | |
JP2017112935A (en) | Powder green juice drink | |
JP2013106590A (en) | Method for improving storage stability of enzym-treated isoquercitrin | |
TW202205968A (en) | Container-packed aspalathin-containing beverage, method for producing same, and method for improving storage stability of aspalathin in container-packed aspalathin-containing beverage | |
JP2008148587A (en) | Polyphenol composition | |
JP5820681B2 (en) | Bitter taste inhibitor | |
JP4168811B2 (en) | Beverage composition | |
JP5869334B2 (en) | Bitter taste inhibitor | |
JP2004305088A (en) | Drink composition | |
JP4311251B2 (en) | Beverage composition | |
JP2004305087A (en) | Drink composition | |
JP7175650B2 (en) | Method for producing tea leaf extract | |
JP7271017B2 (en) | Composition for suppressing elevation of blood cholesterol | |
JP2019118341A (en) | Food product containing polyphenol | |
JP6397559B1 (en) | Green tea beverage containing catechins in high concentration | |
JP2019136008A (en) | Artemisia absinthium extract | |
JP7249764B2 (en) | LIQUID COMPOSITION CONTAINING POLYPHENOLS AND SUPPRESSED PRECIPITATION | |
JP2019001763A (en) | Blood cholesterol rise inhibitory composition | |
JP5744471B2 (en) | Bitter taste inhibitor | |
JP2015091221A (en) | Tea beverage containing quercetin glycoside | |
JP2023089202A (en) | Blood cholesterol rise inhibitory composition |